Online citations, reference lists, and bibliographies.

Nanopharmaceuticals: Principles And Applications Vol. 2

V. K. Yata, Shivendu Ranjan, N. Dasgupta, Eric Lichtfouse
Published 2020 ·

Cite This
Download PDF
Analyze on Scholarcy
Share
Over the last couple of years, several studies have been communicated to endorse the tremendous potential of nanopharmaceuticals for the welfare of human beings and other living organisms. However, very limited concepts have been realized in the form of final products. There are various factors which are responsible for the inadequate development of nanopharmaceuticals such as inherent faults of nanocarrier; implausible absorption, distribution, metabolism, excretion/eliminaP. Verma Department of Biotechnology, Bansal Institute of Engineering and Technology, Lucknow, Uttar Pradesh, India J. K. Ratan (*) Department of Chemical Engineering, Dr. B. R. Ambedkar National Institute of Technology Jalandhar, Jalandhar, Punjab, India e-mail: kumarj@nitj.ac.in
This paper references
10.1016/j.ijpharm.2010.04.029
Enhancement of stability and skin permeation by sucrose stearate and cyclodextrins in progesterone nanoemulsions.
V. Klang (2010)
10.1080/20022727.2017.1325708
Transfersomes as versatile and flexible nano-vesicular carriers in skin cancer therapy: the state of the art
S. Rai (2017)
10.2147/IJN.S65526
Nanopharmaceuticals (part 2): products in the pipeline
V. Weissig (2015)
10.1016/j.coph.2014.09.009
Nano-labelled cells-a functional tool in biomedical applications.
E. Naumenko (2014)
Medicinal weeds of crop fields and role of women in rural health and hygiene in Nalbari district, Assam
Dk Bhattacharjya (2008)
10.1109/ICMENS.2004.126
Preliminary Results of Nanopharmaceuticals Used in the Radioimmunotherapy of Ovarian Cancer
S. McQuarrie (2004)
10.1016/j.jconrel.2013.02.025
Recent advances and future prospects of phyto-phospholipid complexation technique for improving pharmacokinetic profile of plant actives.
J. Khan (2013)
10.1016/S0378-5173(01)00824-9
Interaction of liposome formulations with human skin in vitro.
G. Betz (2001)
10.1038/srep22555
Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR/Cas9 Gene Editing
Rafal Kamiński (2016)
10.1016/J.NANTOD.2012.06.013
Co-delivery of siRNA and therapeutic agents using nanocarriers to overcome cancer resistance.
M. Creixell (2012)
10.1002/jps.24162
The biopharmaceutics risk assessment roadmap for optimizing clinical drug product performance.
A. Selen (2014)
10.1016/J.JCONREL.2007.05.003
Nanotechnology: What it can do for drug delivery.
K. Park (2007)
10.1186/1556-276X-9-340
Preparation and nanoencapsulation of l-asparaginase II in chitosan-tripolyphosphate nanoparticles and in vitro release study
E. Bahreini (2014)
10.1208/s12249-018-1019-y
Transdermal Delivery of Ondansetron Hydrochloride via Bilosomal Systems: In Vitro, Ex Vivo, and In Vivo Characterization Studies
H. Ammar (2018)
10.1016/J.FOODHYD.2006.07.005
Synergistic rheological behaviour of mixed HM/LM pectin gels
C. Löfgren (2007)
10.1208/s12248-013-9546-7
Hyaluronidase-Sensitive Nanoparticle Templates for Triggered Release of HIV/AIDS Microbicide In Vitro
Vivek Agrahari (2013)
10.1039/c2fo30042g
Encapsulation and release of hydrophobic bioactive components in nanoemulsion-based delivery systems: impact of physical form on quercetin bioaccessibility.
Hector Pool (2013)
10.3109/21691401.2014.883401
Vesicular system: Versatile carrier for transdermal delivery of bioactives
D. Singh (2015)
Environmental Protection Agency: Pharmaceuticals and Personal Care Products Drug Disposal and Stewardship (2010) Ramifications for the Environment and Human Health
10.1016/j.jconrel.2016.05.035
Critical evaluation and methodological positioning of the transdermal microdialysis technique. A review.
F. Erdő (2016)
10.1039/c2lc41121k
Microfluidic methods for forming liposomes.
Dirk van Swaay (2013)
10.1208/s12249-017-0771-8
Topical Delivery of Fenoprofen Calcium via Elastic Nano-vesicular Spanlastics: Optimization Using Experimental Design and In Vivo Evaluation
D. Farghaly (2017)
10.1186/1475-2867-12-26
Investigation of the apoptotic way induced by digallic acid in human lymphoblastoid TK6 cells
W. Bhouri (2011)
10.1016/J.INDCROP.2014.12.049
Use of various vegetable oils in designing photoprotective nanostructured formulations for UV protection and antioxidant activity
G. Badea (2015)
10.1007/s11164-013-1338-2
Advances and new technologies applied in controlled drug delivery system
F. Bassyouni (2013)
Pomegranate ellagitannins
D Heber (2011)
Acute inflammation. A Rev
G Ryan (1977)
10.1038/SJ.JID.5700733
Penetration of metallic nanoparticles in human full-thickness skin.
B. Baroli (2007)
10.1002/bies.950171213
Surrogate cells or Trojan horses. The discovery of liposomes.
A. Bangham (1995)
10.1007/978-1-4614-7801-0_3
Portfolio Management in New Drug Development
M. Ding (2014)
10.1093/JAC/DKI125
A new approach for treatment of deep skin infections by an ethosomal antibiotic preparation: an in vivo study.
B. Godin (2005)
10.1016/j.biomaterials.2012.12.017
Dendronized heparin-doxorubicin conjugate based nanoparticle as pH-responsive drug delivery system for cancer therapy.
Wenchuan She (2013)
10.1208/s12249-015-0441-7
Transfersomal Nanoparticles for Enhanced Transdermal Delivery of Clindamycin
Ahmed A. H. Abdellatif (2015)
10.1016/j.biopha.2015.05.002
Improved anti-melanoma effect of a transdermal mitoxantrone ethosome gel.
X. Yu (2015)
10.4314/AJTCAM.V8I1.60483
Extraction, isolation and characterization of bioactive compounds from plants' extracts.
S. Sasidharan (2011)
10.1038/nnano.2014.208
Self-assembled micellar nanocomplexes comprising green tea catechin derivatives and protein drugs for cancer therapy
J. E. Chung (2014)
10.1167/IOVS.05-0280
M cells in the follicle-associated epithelium of the rabbit conjunctiva preferentially bind and translocate latex beads.
Hongshan Liu (2005)
10.14343/JCSCR.2016.4E1002
DOXIL when combined with Withaferin A (WFA) targets ALDH1 positive cancer stem cells in ovarian cancer.
S. Kakar (2016)
10.1016/j.biomaterials.2011.12.037
The use of nano-quercetin to arrest mitochondrial damage and MMP-9 upregulation during prevention of gastric inflammation induced by ethanol in rat.
Somsuta Chakraborty (2012)
10.1186/s12906-015-0718-0
Optimization protocol for the extraction of 6-gingerol and 6-shogaol from Zingiber officinale var. rubrum Theilade and improving antioxidant and anticancer activity using response surface methodology
A. Ghasemzadeh (2015)
10.1021/mp200394t
Nanomedicine(s) under the microscope.
R. Duncan (2011)
10.1148/RADIOL.2301021493
Hepatocellular carcinoma: regional therapy with a magnetic targeted carrier bound to doxorubicin in a dual MR imaging/ conventional angiography suite--initial experience with four patients.
M. Wilson (2004)
10.1208/s12248-012-9339-4
Challenges in Development of Nanoparticle-Based Therapeutics
N. Desai (2012)
10.1148/radiol.14131520
Nanoparticles for imaging: top or flop?
F. Kiessling (2014)
10.1016/j.jconrel.2017.09.002
Non‐covalent formulation of active principles with dendrimers: Current state‐of‐the‐art and prospects for further development
I. El’kin (2017)
10.22038/IJBMS.2015.3890
Safranal-loaded solid lipid nanoparticles: evaluation of sunscreen and moisturizing potential for topical applications
B. Khameneh (2015)
10.2165/00023210-200216090-00001
Potential New Methods for Antiepileptic Drug Delivery
R. Fisher (2002)
10.3109/17435390.2013.826743
Biological impact assessment of nanomaterial used in nanomedicine. Introduction to the NanoTEST project
L. Juillerat-Jeanneret (2015)
10.1016/J.AJPS.2014.06.006
Thin-film hydration preparation method and stability test of DOX-loaded disulfide-linked polyethylene glycol 5000-lysine-di-tocopherol succinate nanomicelles
Xiaoyu Ai (2014)
Project on Emerging Nanotechnologies
Linda K. Breggin (2007)
10.1002/SMLL.200500492
Adverse effects of citrate/gold nanoparticles on human dermal fibroblasts.
N. Pernodet (2006)
10.1016/S0169-409X(02)00044-3
Nanoparticles in cancer therapy and diagnosis.
I. Brigger (2002)
10.2147/IJN.S30725
Liposomes and nanotechnology in drug development: focus on ocular targets
M. Honda (2013)
10.1016/J.JCONREL.2007.11.005
Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: a comparison of whole monoclonal antibody, Fab' fragments and single chain Fv.
W. Cheng (2008)
10.3390/molecules21121719
Nanoparticle-Enabled Transdermal Drug Delivery Systems for Enhanced Dose Control and Tissue Targeting
B. C. Palmer (2016)
10.1016/j.ijpharm.2017.09.059
Preparation of mixed monoterpenes edge activated PEGylated transfersomes to improve the in vivo transdermal delivery efficiency of sinomenine hydrochloride.
J. Wang (2017)
10.3109/21691401.2014.916715
Current nanotechnological approaches for an effective delivery of bio-active drug molecules in the treatment of acne
T. Garg (2016)
10.1007/s11883-014-0435-z
Inflammation and Cardiovascular Disease: From Pathogenesis to Therapeutic Target
E. Golia (2014)
10.4103/0973-1296.157710
Experimental treatment of breast cancer-bearing BALB/c mice by artemisinin and transferrin-loaded magnetic nanoliposomes
A. Gharib (2015)
10.1016/S0005-2736(97)00177-6
Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin.
G. Cevc (1998)
10.1007/s13277-013-1447-y
Dextran-functionalized magnetic fluid mediating magnetohyperthermia for treatment of Ehrlich-solid-tumor-bearing mice: toxicological and histopathological evaluations
A. L. Miranda-Vilela (2013)
10.1016/j.colsurfb.2015.03.025
Cubosome formulations stabilized by a dansyl-conjugated block copolymer for possible nanomedicine applications.
S. Murgia (2015)
10.1016/S0168-3659(01)00290-5
Enhanced skin permeation of a lipophilic drug using supersaturated formulations.
K. Moser (2001)
10.1038/nrd1033
Effect of pegylation on pharmaceuticals
J. Harris (2003)
10.1016/j.biomaterials.2010.08.096
Optimization of surface chemistry on single-walled carbon nanotubes for in vivo photothermal ablation of tumors.
X. Liu (2011)
10.1016/j.jphotobiol.2017.05.023
Perspectives on dendritic architectures and their biological applications: From core to cell.
V. Viswanath (2017)
10.1111/J.1524-4725.2005.31612
Normal Cutaneous Wound Healing: Clinical Correlation with Cellular and Molecular Events
C. Baum (2005)
10.2174/138920012798356934
PEGylation of proteins and liposomes: a powerful and flexible strategy to improve the drug delivery.
P. Milla (2012)
10.1002/smll.200900466
Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage.
Y. Pan (2009)
10.1055/s-0043-102949
Improving on Nature: The Role of Nanomedicine in the Development of Clinical Natural Drugs.
A. Bilia (2017)
10.1016/j.carbpol.2017.07.035
Targeted gene delivery of polyethyleneimine-grafted chitosan with RGD dendrimer peptide in αvβ3 integrin-overexpressing tumor cells.
Young-Min Kim (2017)
10.2174/1568026615666150108150217
Therapeutics and carriers: the dual role of proteins in nanoparticles for ocular delivery.
S. Pescina (2015)
10.1007/s00396-012-2864-y
Ethanol effects on the gelation behavior of α-tocopherol acetate-encapsulated ethosomes with water-soluble polymers
Chun Wei Chiu (2012)
10.1208/s12249-008-9097-x
Conventional and Dense Gas Techniques for the Production of Liposomes: A Review
Louise A. Meure (2008)
mx; miguela.mendez@udlap.mx
10.1006/immu.1994.1021
Liposomes for protein delivery: selecting manufacture and development processes.
A. Weiner (1994)
10.1016/S0378-5173(99)00441-X
Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration.
G. E. El Maghraby (2000)
10.1039/B905635A
Advances and challenges in smart and functional polymer vesicles
J. Du (2009)
10.1080/10611860802475688
Lymphatic targeting of zidovudine using surface-engineered liposomes.
C. D. Kaur (2008)
10.1159/000351815
Turning Theory into Practice: The Development of Modern Transdermal Drug Delivery Systems and Future Trends
O. Perumal (2013)
10.1016/j.biotechadv.2015.08.001
Discovery and resupply of pharmacologically active plant-derived natural products: A review
A. Atanasov (2015)
10.1021/es3001757
Cysteine-induced modifications of zero-valent silver nanomaterials: implications for particle surface chemistry, aggregation, dissolution, and silver speciation.
Andreas P. Gondikas (2012)
10.1016/j.jconrel.2011.03.007
Preclinical to clinical development of the novel camptothecin nanopharmaceutical CRLX101.
Sonke Svenson (2011)
10.1039/B402025A
Magnetic nanoparticle design for medical diagnosis and therapy
S. Mornet (2004)
10.1186/s12302-019-0198-9
Commentary on the draft revised guideline on the environmental risk assessment of medicinal products for human use
R. Whomsley (2019)
10.3109/10717544.2014.980896
Assessment of simvastatin niosomes for pediatric transdermal drug delivery
A. Zidan (2016)
10.1080/08982104.2016.1224897
Preparation and evaluation of niosome gel containing acyclovir for enhanced dermal deposition
Shery Jacob (2017)
10.1016/j.ajps.2017.03.002
Feasibility of drug delivery to the eye's posterior segment by topical instillation of PLGA nanoparticles
Kohei Tahara (2017)
10.1007/s13346-011-0029-z
Using modeling to help understand vaginal microbicide functionality and create better products
D. Katz (2011)
10.1016/J.JIM.2004.10.011
Selection of aptamers with high affinity and high specificity against C595, an anti-MUC1 IgG3 monoclonal antibody, for antibody targeting.
S. Missailidis (2005)
10.3109/03639045.2015.1038274
Lipid nanoparticles as an emerging platform for cannabinoid delivery: physicochemical optimization and biocompatibility
M. Durán-Lobato (2016)
10.4103/0250-474X.40340
Physicochemical and Pharmacokinetic Parameters in Drug Selection and Loading for Transdermal Drug Delivery
N. S. Chandrashekar (2008)
10.1081/DDC-100100984
Permeation Enhancers for Transdermal Drug Delivery
V. Sinha (2000)
10.1039/c3cs60149h
Magnetic nanoparticles as contrast agents in the diagnosis and treatment of cancer.
J. Gallo (2013)
Human serum albumin nanoparticles for efficient delivery of Cu, Zn superoxide dismutase gene
Y. Mo (2007)
10.2174/1567201052772915
Transdermal drug delivery: penetration enhancement techniques.
H. Benson (2005)
10.2147/IJN.S47037
Treating relapsed or refractory Philadelphia chromosome-negative acute lymphoblastic leukemia: liposome-encapsulated vincristine
T. Davis (2013)
10.1155/2015/504253
Role of Polyphenols and Other Phytochemicals on Molecular Signaling
S. Upadhyay (2015)
10.1021/acs.chemrev.5b00116
Clinical Translation of Nanomedicine.
Y. Min (2015)
10.2174/157488551001150825095729
Application of Nanotechnology in Pharmaceutical Formulation Design and Development
Ram S. Thakur and Ruchi Agrawal (2015)
10.1016/J.EJPB.2007.06.010
Polymers and nanoparticles: intelligent tools for intracellular targeting?
M. Breunig (2008)
10.4314/tjpr.v16i12.1
Formulation and characterization of norethisterone transdermal patch as an alternative route to oral administration
Ü. Gönüllü (2018)
Search term: SLIT cisplatin
Clinicaltrials
10.1016/B978-0-12-401716-0.00023-4
Chapter 23 – Rice Bran Oil: Benefits to Health and Applications in Pharmaceutical Formulations
L. A. Rigo (2014)
Therapeutic potential of chitosan
M M Safhi (2016)
The role of anticancer activity of sesquiterpene lactones
K Gach (2015)
10.2217/nnm.10.101
Epigallocatechin gallate-loaded polysaccharide nanoparticles for prostate cancer chemoprevention.
S. Rocha (2011)
10.1208/s12249-011-9584-3
Cyclodextrin-Based Nanosponges for Delivery of Resveratrol: In Vitro Characterisation, Stability, Cytotoxicity and Permeation Study
K. A. Ansari (2011)
10.1089/JMF.2015.3644
Therapeutic Potential of Natural Product-Based Oral Nanomedicines for Stroke Prevention
MutohTatsushi (2016)
10.1021/jf9013923
Evaluation of an oral carrier system in rats: bioavailability and antioxidant properties of liposome-encapsulated curcumin.
M. Takahashi (2009)
10.1080/08982104.2018.1430831
Investigating superiority of novel bilosomes over niosomes in the transdermal delivery of diacerein: in vitro characterization, ex vivo permeation and in vivo skin deposition study
D. Aziz (2019)
10.1093/jac/dkv192
Pulmonary drug delivery: a review on nanocarriers for antibacterial chemotherapy.
M. Moreno-Sastre (2015)
10.1021/mp200522d
Doxorubicin-conjugated PEGylated dendrimers show similar tumoricidal activity but lower systemic toxicity when compared to PEGylated liposome and solution formulations in mouse and rat tumor models.
L. M. Kaminskas (2012)
10.1016/S0378-5173(01)00627-5
Effect of liposomes and niosomes on skin permeation of enoxacin.
J. Fang (2001)
10.1016/S0378-5173(00)00493-2
Skin delivery of oestradiol from lipid vesicles: importance of liposome structure.
G. E. El Maghraby (2000)
10.22377/AJP.V10I2.623
Nanoparticles for Herbal Extracts
Vani Mamillapalli (2016)
10.3109/10611869609046267
Application of liposomes as potential cutaneous drug delivery systems. In vitro and in vivo investigation with radioactively labelled vesicles.
M. Fresta (1996)
10.2217/nnm-2017-0007
Doxorubicin-loaded liposomes: enhancing the oral bioavailability by modulation of physicochemical characteristics.
Marjan Daeihamed (2017)
10.1016/J.CARRES.2006.04.042
A novel one-pot 'green' synthesis of stable silver nanoparticles using soluble starch.
N. Vigneshwaran (2006)
10.1126/SCIENCE.1095833
Drug Delivery Systems: Entering the Mainstream
T. Allen (2004)
10.1016/0005-2736(76)90483-1
Large volume liposomes by an ether vaporization method.
D. Deamer (1976)
Effect of liposome size and drug release properties on pharmacokinetics of encapsulated drug in rats.
T. Allen (1983)
10.3109/21691401.2015.1080169
Optimization, in vitro cytotoxicity and penetration capability of deformable nanovesicles of paclitaxel for dermal chemotherapy in Kaposi sarcoma
K. Pathak (2016)
10.1615/CRITREVTHERDRUGCARRIERSYST.V23.I6.10
Recent progress in dendrimer-based nanocarriers.
Shuhua Bai (2006)
10.1016/j.nano.2012.05.013
The big picture on nanomedicine: the state of investigational and approved nanomedicine products.
M. Etheridge (2013)
10.3109/21691401.2013.837474
Development and characterization of nanocarriers for topical treatment of psoriasis by using combination therapy
Nupur Parnami (2014)
10.1615/CRITREVTHERDRUGCARRIERSYST.2013007419
A pharmacokinetic overview of nanotechnology-based drug delivery systems: an ADME-oriented approach.
M. Hamidi (2013)
10.1002/jsfa.8277
Phytosterols improve immunity and exert anti-inflammatory activity in weaned piglets.
Q. Hu (2017)
10.1016/j.jconrel.2017.05.023
Advances in combination therapy of lung cancer: Rationales, delivery technologies and dosage regimens
L. Wu (2017)
10.3389/fphar.2018.00228
Risk Assessment and Risk Minimization in Nanomedicine: A Need for Predictive, Alternative, and 3Rs Strategies
L. Accomasso (2018)
10.1088/0022-3727/42/22/224001
TOPICAL REVIEW: Progress in applications of magnetic nanoparticles in biomedicine
Q. Pankhurst (2009)
10.1016/j.jconrel.2017.07.030
The drug delivery field at the inflection point: Time to fight its way out of the egg
K. Park (2017)
10.1186/1556-276X-8-176
Gemcitabine-loaded albumin nanospheres (GEM-ANPs) inhibit PANC-1 cells in vitro and in vivo
J. Li (2013)
10.1016/j.cbpc.2014.02.007
Modulation of glutathione and its dependent enzymes in gill cells of Anguilla anguilla exposed to silica coated iron oxide nanoparticles with or without mercury co-exposure under in vitro condition.
K. Srikanth (2014)
10.1021/nn2038252
Reshaping the future of nanopharmaceuticals: ad iudicium.
S. Moghimi (2011)
10.1002/mnfr.201000310
Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin.
V. Kakkar (2011)
10.1016/j.addr.2010.03.011
Tumor delivery of macromolecular drugs based on the EPR effect.
V. Torchilin (2011)
Fabrication and evaluation of the novel reductionsensitive starch nanoparticles for controlled drug release
J Yang (2014)
10.1016/j.jconrel.2017.01.014
BCS class IV drugs: Highly notorious candidates for formulation development
R. Ghadi (2017)
10.1002/ptr.2493
Cytotoxic constituents from Andrographis paniculata induce cell cycle arrest in jurkat cells.
Madamanchi Geethangili (2008)
10.1016/j.ejps.2010.06.012
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma.
B. Ruozi (2010)
10.2174/1872211312666180105114644
Patented and Approval Scenario of Nanopharmaceuticals with Relevancy to Biomedical Application, Manufacturing Procedure and Safety Aspects.
V. Agarwal (2018)
10.1080/10717544.2016.1176087
Quercetin-loaded poly (lactic-co-glycolic acid)-d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for the targeted treatment of liver cancer
X. Guan (2016)
10.1038/nrclinonc.2015.105
Inflammation and cancer: advances and new agents
S. Crusz (2015)
10.1016/0005-2736(94)90038-8
Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes.
D. C. Litzinger (1994)
10.1007/s11095-014-1559-0
Formulation and Pharmacokinetics of Thermosensitive Stealth® Liposomes Encapsulating 5-Fluorouracil
Chantal Al Sabbagh (2014)
10.1016/j.ijpharm.2013.08.040
Formulation, characterization and pharmacokinetics of Morin hydrate niosomes prepared from various non-ionic surfactants.
Ayman Yahia Waddad (2013)
10.1007/s11095-017-2165-8
A Functional Iron Oxide Nanoparticles Modified with PLA-PEG-DG as Tumor-Targeted MRI Contrast Agent
F. Xiong (2017)
10.1016/j.ijpharm.2017.05.016
Paclitaxel: What has been done and the challenges remain ahead.
E. Bernabeu (2017)
10.1016/J.JCONREL.2005.04.007
Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers.
D. Paolino (2005)
10.1016/j.ijpharm.2011.03.049
Liposome surface charge influence on skin penetration behaviour.
A. Gillet (2011)
10.1007/s13346-014-0202-2
Treatment of cutaneous candidiasis through fluconazole encapsulated cubosomes
Vijay Prajapati (2014)
10.1038/sj.bjc.6605535
The low-molecular-weight heparin, nadroparin, inhibits tumour angiogenesis in a rodent dorsal skinfold chamber model
I. Debergh (2010)
10.1111/j.2042-7158.1982.tb04767.x
Liposomes--a selective drug delivery system for the topical route of administration: gel dosage form.
M. Mezei (1982)
10.1016/j.fitote.2010.05.001
Applications of novel drug delivery system for herbal formulations.
Ajazuddin (2010)
10.4103/0974-9233.106384
Nanotechnology Approaches for Ocular Drug Delivery
Qingguo Xu (2013)
10.1016/S0163-7827(03)00033-X
Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties.
S. Moghimi (2003)
10.2147/IJN.S13816
Nanomedicine: promises and challenges for the future of public health
Michelle Pautler (2010)
10.1016/j.jconrel.2009.10.002
Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy.
P. Pradhan (2010)
10.1088/0957-4484/19/40/405102
Magnetic nanoparticles as gene delivery agents: enhanced transfection in the presence of oscillating magnet arrays.
S C McBain (2008)
10.1016/S1461-5347(00)00317-5
Non-invasive administration of drugs through the skin: challenges in delivery system design.
Foldvari (2000)
10.1016/J.ORGEL.2014.06.027
Starch: Application of biopolymer in random lasing
Konrad Cyprych (2014)
10.1016/j.colsurfb.2017.04.025
Dendrimer-conjugated iron oxide nanoparticles as stimuli-responsive drug carriers for thermally-activated chemotherapy of cancer.
Saumya Nigam (2017)
10.1016/S0939-6411(03)00040-7
The influence of solid lipid nanoparticles on skin hydration and viscoelasticity--in vivo study.
S. Wissing (2003)
Excellent antiproliferative and pro-apoptotic effects of ( − ) -epigallocatechin-3-gallate encapsulated in chitosan nanoparticles on human melanoma cell growth both in vitro and in vivo
I A Siddiqui (2014)
10.1039/C6TB01925K
Polymeric nanoparticles for colon cancer therapy: overview and perspectives.
Xinru You (2016)
10.1211/0022357001774813
Effect of ion pairing with alkylamines on the in-vitro dermal penetration and local tissue disposition of salicylates.
S. A. Megwa (2000)
10.3109/08982104.2013.819888
Essential oils encapsulated in liposomes: a review
Mirna Sherry (2013)
10.1016/J.EJPB.2006.08.011
Fate of micelles and quantum dots in cells.
D. Maysinger (2007)
10.1080/17425247.2016.1205585
Clinical advances of nanocarrier-based cancer therapy and diagnostics
E. Luque-Michel (2017)
10.1016/j.jconrel.2011.10.035
Polyethyleneimine-based core-shell nanogels: a promising siRNA carrier for argininosuccinate synthetase mRNA knockdown in HeLa cells.
H. Mimi (2012)
10.1016/0005-2736(95)00100-H
Interaction of phosphatidylcholine liposomes with the human stratum corneum.
S. Zellmer (1995)
10.1038/s41598-017-12150-8
AS1411 Aptamer-Anionic Linear Globular Dendrimer G2-Iohexol Selective Nano-Theranostics
P. Mohammadzadeh (2017)
10.1021/LA070051A
Microfluidic directed formation of liposomes of controlled size.
A. Jahn (2007)
10.1039/B911371A
Colloidal phytosterols: synthesis, characterization and bioaccessibility
L. Rossi (2010)
Ethosomes : A Novel Vesicular Carrier For Enhanced Transdermal Delivery Of An AntiHIV Agent
S. Jain (2004)
10.1007/12_2009_40
Polymersomes: A Synthetic Biological Approach to Encapsulation and Delivery
M. Massignani (2010)
10.1016/j.addr.2015.02.001
Mucoadhesive and thermogelling systems for vaginal drug delivery.
C. Caramella (2015)
10.1016/j.ejps.2008.05.002
Liposomes and skin: from drug delivery to model membranes.
G. E. El Maghraby (2008)
10.1038/nchem.2396
Recent advances in the molecular design of synthetic vaccines.
L. Jones (2015)
10.1016/S0022-2836(65)80093-6
Diffusion of univalent ions across the lamellae of swollen phospholipids.
A. Bangham (1965)
10.1016/J.IJPHARM.2006.08.002
In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin.
A. Pardakhty (2007)
10.4269/ajtmh.1951.s1-31.842
Studies of diffusion of water through dead human skin; the effect of different environmental states and of chemical alterations of the epidermis.
G. Berenson (1951)
Adverse Events with Biomedicines: Prevention Through Understanding
G. Tridente (2013)
10.1517/14712598.5.1.1
Nanomedicine – prospective therapeutic and diagnostic applications
D. Emerich (2005)
10.1016/S1773-2247(14)50087-1
Proniosomes as a novel drug carrier system for buccal delivery of benzocaine
S. H. A. El-Alim (2014)
10.1016/j.peptides.2012.07.021
Predicting antimicrobial peptides from eukaryotic genomes: In silico strategies to develop antibiotics
A. C. Amaral (2012)
10.1016/j.colsurfb.2011.07.058
Studies on pectin coating of liposomes for drug delivery.
S. Nguyen (2011)
10.1016/J.JCONREL.2003.10.014
Mechanism of bacitracin permeation enhancement through the skin and cellular membranes from an ethosomal carrier.
B. Godin (2004)
10.1016/S0378-5173(03)00183-2
Particle size of liposomes influences dermal delivery of substances into skin.
D. Verma (2003)
10.1080/17435390802398309
Toxicological assessment of orally delivered nanoparticulate insulin
C. Reis (2008)
10.1016/0168-3659(96)01349-1
The effects of phospholipids on the percutaneous penetration of indomethacin through the dorsal skin of guinea pig in vitro. 2. The effects of the hydrophobic group in phospholipids and a comparison with general enhancers
Yuichi Yokomizo (1996)
10.2147/IJN.S34348
Biocompatibility of chitosan-coated iron oxide nanoparticles with osteoblast cells
Si-Feng Shi (2012)
10.2174/1872213X11307010049
Aerodynamics and deposition effects of inhaled submicron drug aerosol in airway diseases.
Md Faiyazuddin (2013)
10.1111/jphp.12590
TPGS-modified liposomes for the delivery of ginsenoside compound K against non-small cell lung cancer: formulation design and its evaluation in vitro and in vivo.
L. Yang (2016)
10.3945/jn.109.117168
Anthocyanins are bioavailable in humans following an acute dose of cranberry juice.
P. Milbury (2010)
10.3109/1061186X.2013.765442
The application of nanoemulsion in dermatology: an overview
Y. Wu (2013)
10.1211/JPP.57.12.0005
Size-dependent disposition of nanoparticles and microparticles following subconjunctival administration.
A. Amrite (2005)
10.1159/000085861
Sunscreen Penetration of Human Skin and Related Keratinocyte Toxicity after Topical Application
C. Hayden (2005)
10.1016/0020-711x(89)90249-8
Transdermal Drug Delivery
P. Uzor (2012)
10.1016/0168-3659(95)00088-7
Mechanism of oleic acid-induced skin penetration enhancement in vivo in humans
A. Naik (1995)
10.1515/acph-2017-0021
Pharmacokinetic studies and anticancer activity of curcumin-loaded nanostructured lipid carriers
Fengling Wang (2017)
10.1016/0168-3659(96)01354-5
Iontophoretic delivery of peptide drugs
P. G. Green (1996)
10.2174/156720106777731019
Liposomes and micro/nanoparticles as colloidal carriers for nasal drug delivery.
R. Mainardes (2006)
10.1016/j.ejpb.2016.04.018
Confocal Raman microscopy and multivariate statistical analysis for determination of different penetration abilities of caffeine and propylene glycol applied simultaneously in a mixture on porcine skin ex vivo.
Saul Mujica Ascencio (2016)
10.1021/JM010893L
Design and optimization of 20-O-linked camptothecin glycoconjugates as anticancer agents.
H. Lerchen (2001)
10.1155/2012/270383
Preparation of Lipid Nanoemulsions Incorporating Curcumin for Cancer Therapy
S. Anuchapreeda (2012)
Global cancer facts and figures
(2015)
10.1016/j.canlet.2012.11.037
Nanoformulation of natural products for prevention and therapy of prostate cancer.
V. Sanna (2013)
10.1016/0006-291X(92)91318-K
Common peptide epitopes in glycophorin and the endothelial sialoglycoprotein gp60.
J. Schnitzer (1992)
10.1016/j.jconrel.2013.05.011
Formation of artificial multicompartment vesosome and dendrosome as prospected drug and gene delivery carriers.
C. Paleos (2013)
10.1016/j.bbagen.2013.02.008
Natural products: a continuing source of novel drug leads.
G. Cragg (2013)
10.3109/02656736.2014.1000393
Focused ultrasound influence on calcein-loaded thermosensitive stealth liposomes
A. Novell (2015)
10.1016/j.cis.2008.09.002
Silver nanoparticles: green synthesis and their antimicrobial activities.
V. Sharma (2009)
10.1111/j.1365-2184.1994.tb01413.x
Effects of mitomycin C and porfiromycin on exponentially growing and plateau phase cultures
S. Rockwell (1994)
Chapter 2: Nanoliposomes: preparation and analysis
M R Mozafari (2010)
Anticancer activity of resveratrolloaded gelatin nanoparticles on NCI-H460 non-small cell lung cancer cells
S Karthikeyan (2013)
An in vitro and in vivo study of gemcitabineloaded albumin nanoparticles in a pancreatic cancer cell line
X Yu (2015)
Nanotechnologies -vocabulary -Part 2: Nano-objects. International Organization for Standardization
Iso (2015)
Nanopharmaceuticals for drug delivery: a review
R Bawa (2009)
10.1021/mp9002464
Dendrimer internalization and intracellular trafficking in living cells.
L. Albertazzi (2010)
10.2174/1567201814666170224141548
Formulation of Niosomal Gel for Enhanced Transdermal Lornoxicam Delivery: In-Vitro and In-Vivo Evaluation.
M. El-Ridy (2018)
10.1007/S12668-016-0267-0
Towards the Fabrication of Polyelectrolyte-Based Nanocapsules for Bio-Medical Applications
L. Pastorino (2016)
10.1016/j.ijpharm.2015.04.054
In vitro and in vivo evaluation of Δ⁹-tetrahidrocannabinol/PLGA nanoparticles for cancer chemotherapy.
L. Martín-Banderas (2015)
10.1016/j.ijpharm.2008.08.032
Micro-scale devices for transdermal drug delivery.
A. Arora (2008)
10.1021/mp300489p
Phytosomes loaded with mitomycin C-soybean phosphatidylcholine complex developed for drug delivery.
Z. Hou (2013)
10.1208/pt050456
Stabilized nanoparticles of phytosterol by rapid expansion from supercritical solution into aqueous solution
M. Türk (2008)
10.1158/1078-0432.CCR-04-2482
Antiangiogenic Properties of Gold Nanoparticles
Priyabrata Mukherjee (2005)
10.1016/j.yexmp.2008.12.004
Nanoparticle-based targeted drug delivery.
R. Singh (2009)
10.1016/j.nano.2008.04.003
Carbon nanotubes as functional excipients for nanomedicines: II. Drug delivery and biocompatibility issues.
M. Foldvari (2008)
10.1007/s11095-007-9284-6
Poly(ethylene glycol)-modified Nanocarriers for Tumor-targeted and Intracellular Delivery
L. E. V. Vlerken (2007)
10.1007/978-1-4614-7801-0_1
The Pharmaceutical Industry: Specificity, Challenges, and What You Can Learn from this Book
M. Ding (2014)
10.1016/j.jconrel.2014.04.015
Nano-niosomes as nanoscale drug delivery systems: an illustrated review.
Saeid Moghassemi (2014)
10.1186/2228-5326-2-32
Silver nanoparticles: mechanism of antimicrobial action, synthesis, medical applications, and toxicity effects
S. Prabhu (2012)
10.1021/MP0500014
Iron oxide nanoparticles for sustained delivery of anticancer agents.
Tapan Jain (2005)
10.1016/j.aquatox.2016.05.005
Chronic exposure of tilapia (Oreochromis niloticus) to iron oxide nanoparticles: Effects of particle morphology on accumulation, elimination, hematology and immune responses.
M. Ates (2016)
The nanomedicine revolution: part 3: regulatory and safety challenges.
C. Ventola (2012)
10.1016/j.xphs.2016.10.001
Recent Advances in Lipid-Based Vesicles and Particulate Carriers for Topical and Transdermal Application.
Shashank Jain (2017)
10.4155/tde.13.104
Basics and recent advances in peptide and protein drug delivery.
Benjamin J. Bruno (2013)
10.1016/j.ijpharm.2009.05.054
Formulation and characterization of polyphenol-loaded lipid nanocapsules.
A. Barras (2009)
10.1155/2011/517204
Anticancer Potentials of Root Extract of Polygala senega and Its PLGA Nanoparticles-Encapsulated Form
S. Paul (2011)
10.1007/s11095-007-9308-2
Transdermal Delivery of Interferon Alpha-2B using Microporation and Iontophoresis in Hairless Rats
A. Badkar (2007)
10.1016/j.addr.2016.05.024
DNA nanovehicles and the biological barriers.
A. Okholm (2016)
10.1158/1535-7163.MCT-09-0366
Microtubule inhibitors: Differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance
E. Perez (2009)
Nanoparticle vesicular systems : A versatile tool for drug delivery
S. Verma (2010)
10.1164/RCCM.200504-613PP
The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis.
S. Gelperina (2005)
10.1016/j.marenvres.2015.06.013
Ecotoxicological impact of engineered nanomaterials in bivalve molluscs: An overview.
T. Rocha (2015)
10.1016/j.nano.2010.01.002
Enhanced transdermal delivery of an anti-HIV agent via ethanolic liposomes.
V. Dubey (2010)
10.1016/j.biopha.2017.06.043
Formulation and optimization of lacidipine loaded niosomal gel for transdermal delivery: In-vitro characterization and in-vivo activity.
Mohd Qumbar (2017)
10.1016/j.ijpharm.2015.09.020
Artemisinin nanoformulation suitable for intravenous injection: Preparation, characterization and antimalarial activities.
N. Ibrahim (2015)
10.1016/j.addr.2012.08.005
Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine.
Xue-Qing Zhang (2012)
10.1007/s11051-010-9911-8
Toxicity and cellular uptake of gold nanoparticles: what we have learned so far?
A. AlKilany (2010)
10.3978/j.issn.2223-4292.2012.09.01
Heparin based nanoparticles for cancer targeting and noninvasive imaging.
M. Nurunnabi (2012)
Iron oxide nanoparticles to an Indian major carp, Labeo rohita: impacts on hematology, ion regulation and gill Na+/K+ ATPase activity
A M Ribeiro (2015)
Proteinnanoparticle interactions: opportunities and challenges
M Mahmoudi (2011)
10.1210/en.2009-1082
Nanoparticles and the immune system.
Banu S. Zolnik (2010)
10.1111/1523-1747.ep12531118
Hydration and percutaneous absorption: I. Influence of hydration on alkanol permeation through hairless mouse skin.
C. R. Behl (1980)
10.1007/s13346-015-0220-8
Influence of cholesterol on liposome stability and on in vitro drug release
Maria-Lucia Briuglia (2015)
10.1208/s12249-017-0786-1
Dual-Prevention for UV-Induced Skin Damage: Incorporation of Melatonin-Loaded Elastic Niosomes into Octyl Methoxycinnamate Pickering Emulsions
Gulcin Arslan Azizoglu (2017)
10.1371/journal.pone.0092978
Microfluidic-Enabled Liposomes Elucidate Size-Dependent Transdermal Transport
R. R. Hood (2014)
10.1134/S1070363213120505
Development strategies and biopharmaceutical aspects of drug delivery systems
N. Demina (2013)
10.1517/17425247.2013.779252
Skin permeation behavior of elastic liposomes: role of formulation ingredients
J. Chen (2013)
10.1159/000112961
Nanomedicine: Application of Nanobiotechnology in Medical Practice
K. Jain (2008)
Preparation and Evaluation of Imiquimod Loaded Liposomal Dispersion: Part-I
Tanmay N. Patel (2013)
10.1016/j.tox.2009.08.016
From ecotoxicology to nanoecotoxicology.
A. Kahru (2010)
10.1615/CRITREVTHERDRUGCARRIERSYST.V25.I6.20
A review of the application of lipid-based systems in systemic, dermal/ transdermal, and ocular drug delivery.
P. Gershkovich (2008)
10.1158/1940-6207.CAPR-10-0006
Advanced Drug Delivery Systems of Curcumin for Cancer Chemoprevention
Shyam S. Bansal (2011)
10.1007/S10856-007-3193-4
PEGylated synthetic surfactant vesicles (Niosomes): novel carriers for oligonucleotides
Yongzhuo Huang (2008)
10.1016/j.ijpharm.2015.03.020
Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study.
A. Abdelbary (2015)
10.1016/j.colsurfb.2015.11.050
Improved oral delivery of resveratrol from N-trimethyl chitosan-g-palmitic acid surface-modified solid lipid nanoparticles.
P. Ramalingam (2016)
10.1016/j.ijpharm.2015.08.053
Photostability and ex-vivo permeation studies on diclofenac in topical niosomal formulations.
G. Ioele (2015)
Acute toxicity and pharmacokinetics of 13 nm-sized PEGcoated gold nanoparticles
W S Cho (2009)
Clinical comparison between paclitaxel liposome (Lipusu(R)) and paclitaxel for treatment of patients with metastatic gastric cancer
X Xu (2013)
Evolutionary approaches for drug and gene delivery by micro and nano magnetic carriers. Indo-global
T Garg (2012)
10.1007/s11883-017-0646-1
The Role of Inflammation in Cardiovascular Outcome
F. Montecucco (2017)
10.1016/j.biopha.2016.12.099
A brief review on the application of nanoparticle enclosed herbal medicine for the treatment of infective endocarditis.
M. Namdari (2017)
10.1016/J.TIFS.2011.01.002
Applications of nanomaterials in food packaging with a consideration of opportunities for developing countries
E. Bradley (2011)
10.1016/j.addr.2009.11.019
Pure drug and polymer based nanotechnologies for the improved solubility, stability, bioavailability and targeting of anti-HIV drugs.
P. Sharma (2010)
10.1080/03639045.2017.1287717
Nanoethosomes for transdermal delivery of tropisetron HCl: multi-factorial predictive modeling, characterization, and ex vivo skin permeation
Hanaa A Abdel Messih (2017)
10.1111/j.1365-2133.1988.tb03262.x
Decreased stratum corneum cerarnides in atopic individuals—a pathobiochemical factor in xerosis?
B. Melnik (1988)
10.1016/j.ijpharm.2013.06.052
Selection of high efficient transdermal lipid vesicle for curcumin skin delivery.
Yingzheng Zhao (2013)
10.1023/B:PHAM.0000045229.87844.21
Novel Long-Circulating Lipid Nanocapsules
D. Hoarau (2004)
10.1016/j.colsurfb.2016.07.043
Polymer-associated liposomes for the oral delivery of grape pomace extract.
M. Manconi (2016)
10.1016/J.REACTFUNCTPOLYM.2006.05.006
In situ preparation of magnetic chitosan/Fe3O4 composite nanoparticles in tiny pools of water-in-oil microemulsion
J. Zhi (2006)
10.1016/B978-0-323-47347-7.00027-6
Multifunctional Magnetic Liposomes for Cancer Imaging and Therapeutic Applications
Manashjit Gogoi (2016)
10.1016/j.colsurfb.2014.11.005
Paclitaxel/epigallocatechin gallate coloaded liposome: a synergistic delivery to control the invasiveness of MDA-MB-231 breast cancer cells.
Satiesh kumar Ramadass (2015)
10.1517/13543784.2011.576666
Paclitaxel poliglumex for ovarian cancer
V. Galic (2011)
10.1007/BF02968008
Mechanism of taxane neurotoxicity
Hiroki Hagiwara (2004)
10.1016/j.ejps.2013.04.035
Nanopharmaceuticals for improved topical vaginal therapy: can they deliver?
Željka Vanić (2013)
10.1016/j.biomaterials.2011.06.073
The treatment of bladder cancer in a mouse model by epigallocatechin-3-gallate-gold nanoparticles.
Dar-Shih Hsieh (2011)
10.4155/tde.15.62
Identifying present challenges to reliable future transdermal drug delivery products.
S. A. Giannos (2015)
10.1002/DDR.20067
Magnetic nanoparticles for drug delivery
J. Dobson (2006)
10.2147/IJN.S56932
Polymeric nanoparticles for targeted treatment in oncology: current insights
R. Prabhu (2015)
10.1007/978-1-4614-7801-0_8
Pharmaceutical Lifecycle Extension Strategies
E. Kappe (2014)
10.1016/j.ijpharm.2010.06.034
Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery.
Ghada M El Zaafarany (2010)
10.1002/med.21420
Nanotechnology in Glycomics: Applications in Diagnostics, Therapy, Imaging, and Separation Processes
Erika Dosekova (2017)
10.1016/j.carbpol.2015.05.030
Current state on the development of nanoparticles for use against bacterial gastrointestinal pathogens. Focus on chitosan nanoparticles loaded with phenolic compounds.
A. R. Madureira (2015)
NOVEL DRUG DELIVERY SYSTEM IN HERBAL'S
Kharat Amol (2014)
10.1200/JCO.2005.04.937
Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer.
W. Gradishar (2005)
10.1016/0024-3205(80)90268-4
Liposomes--a selective drug delivery system for the topical route of administration. Lotion dosage form.
M. Mezei (1980)
10.1002/CPHY.CP090119
Permeability of the skin.
R. Scheuplein (1971)
10.3390/nano7110379
Increased Loading, Efficacy and Sustained Release of Silibinin, a Poorly Soluble Drug Using Hydrophobically-Modified Chitosan Nanoparticles for Enhanced Delivery of Anticancer Drug Delivery Systems
Cha Yee Kuen (2017)
10.1016/j.actbio.2016.04.026
Paclitaxel-loaded solid lipid nanoparticles modified with Tyr-3-octreotide for enhanced anti-angiogenic and anti-glioma therapy.
Indranil Banerjee (2016)
10.1016/S0928-0987(98)00041-4
Investigation of the mechanism of flux across human skin in vitro by quantitative structure-permeability relationships.
M. Cronin (1999)
Development and characterization of protein loaded poly-lactideco-glycolide nanospheres
M D Blanco (1997)
In vitro antioxidant properties of the diterpenes Parvifloron D and 7α-acetoxy-6β-hydroxyroyleanone
S Rosa (2015)
Anticancer properties of Allium sativum -a review
R Ranjani (2012)
10.2147/IJN.S46900
Nanopharmaceuticals (part 1): products on the market
V. Weissig (2014)
10.1080/10837450.2016.1200615
How can lipid nanocarriers improve transdermal delivery of olanzapine?
N. Iqbal (2017)
10.1016/J.CBPA.2006.01.006
Nanotechnologies for biomolecular detection and medical diagnostics.
M. Cheng (2006)
10.1039/c7dt02424j
Triple function nanocomposites of porous silica-CoFe2O4-MWCNTs as a carrier for pH-sensitive anti-cancer drug controlled delivery.
Huitao Fan (2017)
10.1371/journal.pone.0159967
Ethosomes Loaded with Cryptotanshinone for Acne Treatment through Topical Gel Formulation
Zhenwei Yu (2016)
Some anticancer medicinal plants of foreign origin
S. Madhuri (2009)
10.1080/03602530701690366
Drug-Metabolizing Enzymes in the Skin of Man, Rat, and Pig
F. Oesch (2007)
10.2217/nnm.10.35
Nanomedicinal strategies to treat multidrug-resistant tumors: current progress.
X. Dong (2010)
10.1016/j.watres.2012.12.043
The zerovalent iron nanoparticle causes higher developmental toxicity than its oxidation products in early life stages of medaka fish.
Pei-jen Chen (2013)
10.1159/000056393
Modulation of the Barrier Function of the Skin
J. Hadgraft (2001)
10.9790/3013-0220338339
PULSATILE DRUG DELIVERY SYSTEMS: PULSINCAP SYSTEM
T. Garg (2012)
10.1016/j.ejpb.2016.03.005
Encapsulation of cannabinoid drugs in nanostructured lipid carriers.
E. Esposito (2016)
10.1016/j.jphotobiol.2016.09.032
Synthesis, characterization, anti-bacterial, anti-fungal and nematicidal activities of 2-amino-3-cyanochromenes.
Muhammad Nawaz (2016)
10.1002/9781118140505.CH3
Electrical and physical methods of skin penetration enhancement
J. Grice (2012)
10.1186/2008-2231-21-14
Different biokinetics of nanomedicines linking to their toxicity; an overview
Sara Mostafalou (2013)
10.2217/nnm-2017-0049
Redox biology of Leishmania and macrophage targeted nanoparticles for therapy.
H. S. Sarwar (2017)
10.1118/1.595079
Clinical prospects for liposomes.
M. Yatvin (1982)
10.1021/ja808541r
Thermodynamic analysis of the effect of cholesterol on dipalmitoylphosphatidylcholine lipid membranes.
W. Bennett (2009)
10.2147/IJN.S16044
Preparation of a ligustrazine ethosome patch and its evaluation in vitro and in vivo
Xingyan Liu (2011)
10.1371/journal.pone.0109970
Tenfibgen Ligand Nanoencapsulation Delivers Bi-Functional Anti-CK2 RNAi Oligomer to Key Sites for Prostate Cancer Targeting Using Human Xenograft Tumors in Mice
J. H. Trembley (2014)
10.1016/j.pharmthera.2011.09.002
Phytocannabinoids as novel therapeutic agents in CNS disorders.
A. Hill (2012)
10.1080/10837450701831211
Feasibility of proniosomes-based transdermal delivery of frusemide: formulation optimization and pharmacotechnical evaluation.
A. Azeem (2008)
10.1186/1471-2121-10-65
Anti-proliferative activity of silver nanoparticles
P. Asharani (2009)
10.2174/0929867311209025029
Functional nanogels for biomedical applications.
M. Asadian-Birjand (2012)
10.3109/10717544.2013.838077
Recent advances in non-ionic surfactant vesicles (niosomes): self-assembly, fabrication, characterization, drug delivery applications and limitations
H. Abdelkader (2014)
10.1016/j.ijpharm.2015.03.033
Investigating the potential of employing bilosomes as a novel vesicular carrier for transdermal delivery of tenoxicam.
A. M. Al-mahallawi (2015)
10.1016/j.drudis.2016.11.005
Doxorubicin: nanotechnological overviews from bench to bedside.
Maximiliano Cagel (2017)
10.1021/CG4000473
Nanocrystal Preparation: Low-Energy Precipitation Method Revisited
Shahzeb Khan (2013)
10.1016/j.aquatox.2017.08.004
Integrated assessment of toxic effects of maghemite (γ-Fe2O3) nanoparticles in zebrafish.
R. A. Villacis (2017)
10.1021/mp800051m
Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles
F. Alexis (2008)
Deformable liposomes and ethosomes as carriers for skin delivery of ketotifen.
M. M. Elsayed (2007)
10.1002/9781118451915.CH35
Bioavailability and Delivery of Nutraceuticals and Functional Foods Using Nanotechnology
H. Yu (2013)
Long-circulating nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate).
C. Passirani (1998)
10.3109/07357900903179591
Phase II Clinical Trial of Paclitaxel Loaded Polymeric Micelle in Patients with Advanced Pancreatic Cancer
M. Saif (2010)
10.1016/j.scitotenv.2016.01.085
Effects of nanomaterials on marine invertebrates.
L. Canesi (2016)
10.1159/000086137
Pathophysiology of Acute Pancreatitis
R. Schmid (2005)
10.1016/j.ejps.2016.12.026
Evaluation of paeonol‐loaded transethosomes as transdermal delivery carriers
Z. Chen (2017)
10.1111/imm.12233
Inflammation in neurodegenerative diseases--an update.
S. Amor (2014)
10.22377/AJP.V3I2.245
Biopharmaceutical classification system: A strategic tool for oral drug delivery technology
N. K. Sachan (2009)
10.1016/J.IJPHARM.2006.12.005
Lipid vesicles for skin delivery of drugs: reviewing three decades of research.
M. M. Elsayed (2007)
10.1186/1748-717X-9-150
Hafnium oxide nanoparticles: toward an in vitro predictive biological effect?
Julie Marill (2014)
10.1517/17425240903071029
Vesicular carriers for dermal drug delivery
C. Sinico (2009)
10.3109/10837450.2013.879886
Influence of electronic and formulation variables on transdermal iontophoresis of tacrine hydrochloride
N. Patel (2015)
10.1016/J.TIV.2005.06.034
In vitro toxicity of nanoparticles in BRL 3A rat liver cells.
S. Hussain (2005)
10.2147/IJN.S105016
Ethosomal nanocarriers: the impact of constituents and formulation techniques on ethosomal properties, in vivo studies, and clinical trials
Ibrahim M. Abdulbaqi (2016)
10.2174/156720111795256156
Regulating nanomedicine - can the FDA handle it?
R. Bawa (2011)
10.1080/03639045.2017.1318907
Optimization of methotrexate loaded niosomes by Box–Behnken design: an understanding of solvent effect and formulation variability
Ahmed S. Zidan (2017)
10.1039/C5TB01917F
Synthesis, characterization, antibacterial activity and cytotoxicity of hollow TiO2-coated CeO2 nanocontainers encapsulating silver nanoparticles for controlled silver release.
Jacinthe Gagnon (2016)
10.1016/j.actbio.2013.08.016
Graphene and graphene oxide as new nanocarriers for drug delivery applications.
J. Liu (2013)
Advances in Brief Tea Polyphenol ( )-Epigallocatechin-3-Gallate Inhibits DNA Methyltransferase and Reactivates Methylation-Silenced Genes in Cancer Cell Lines
M. Fang (2003)
10.1097/MPA.0000000000001034
Protective Effect of Scopoletin Against Cerulein-Induced Acute Pancreatitis and Associated Lung Injury in Mice
George Leema (2018)
Herbal Cosmetics for Skin and Hair care
Virendra P. Kapoor (2005)
10.1016/j.ijpharm.2017.01.014
Docosahexaenoic acid loaded lipid nanoparticles with bactericidal activity against Helicobacter pylori.
C. L. Seabra (2017)
10.3109/08982100903347923
Ethanol injection method for hydrophilic and lipophilic drug-loaded liposome preparation
C. Jaafar-Maalej (2010)
10.1038/sj.bjp.0707130
Nanoparticles: pharmacological and toxicological significance
C. Medina (2007)
10.4103/2231-4040.101006
Influence of nanotechnology on herbal drugs: A Review
S. Ansari (2012)
10.1016/J.JEP.2006.11.036
Topical anti-inflammatory, gastroprotective and antioxidant effects of the essential oil of Lippia sidoides Cham. leaves.
M. B. Monteiro (2007)
10.2217/nnm.15.166
Nanoparticle systems reduce systemic toxicity in cancer treatment.
H. Wang (2016)
Dendrimers: A Tool for Drug Delivery
Anirudha Malik (2012)
Abraxane_ABI-007)_in_the_treatment_of_ breast_cancer/links/0fcfd50b905b7520b3000000
Albumin-BoundFormulationOfPaclitaxel
Direct fabrication and harvesting of direct fabrication and harvesting of monodisperse
J P Rolland (2005)
Process for the production of dispersions of lipidic droplets in water and new compositions based on same
G Vanlerberghe (1975)
280 Index Perrone
N Pernodet
10.2147/IJN.S3061
Albumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancer
E. Miele (2009)
10.1016/j.actatropica.2017.02.019
Nanopharmaceuticals as a solution to neglected diseases: Is it possible?
G. A. Islan (2017)
10.1021/mp800240j
Coadministration of Paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells.
Srinivas Ganta (2009)
10.1166/JBN.2014.1884
Nanopharmaceutics: phytochemical-based controlled or sustained drug-delivery systems for cancer treatment.
R. Jeetah (2014)
10.1002/tcr.201000008
Nanogel engineering for new nanobiomaterials: from chaperoning engineering to biomedical applications.
Y. Sasaki (2010)
10.1016/j.drudis.2016.06.029
RNAi-combined nano-chemotherapeutics to tackle resistant tumors.
Rakesh K Tekade (2016)
10.1016/j.cis.2015.04.006
Nanocarriers for the delivery of active ingredients and fractions extracted from natural products used in traditional Chinese medicine (TCM).
Ying Liu (2015)
10.1208/s12249-016-0489-z
Systematic Development of Transethosomal Gel System of Piroxicam: Formulation Optimization, In Vitro Evaluation, and Ex Vivo Assessment
Varun Garg (2016)
10.1002/JPS.20849
Dendrimers as a carrier for pulmonary delivery of enoxaparin, a low-molecular weight heparin.
Shuhua Bai (2007)
10.1155/2017/5165268
Inflammatory Regulation in Diabetes and Metabolic Dysfunction
Jixin Zhong (2017)
10.1016/j.jcis.2014.08.064
Quercetin conjugated superparamagnetic magnetite nanoparticles for in-vitro analysis of breast cancer cell lines for chemotherapy applications.
S. R. Kumar (2014)
10.12659/MSM.894484
Self-Assembled Cubic Liquid Crystalline Nanoparticles for Transdermal Delivery of Paeonol
J. Li (2015)
10.1038/nrd2591
Strategies in the design of nanoparticles for therapeutic applications
Robby A. Petros (2010)
10.2147/IJN.S52634
Nanotechnology-based drug delivery systems and herbal medicines: a review
B. Bonifácio (2014)
10.1038/nrc3982
Glycosylation in cancer: mechanisms and clinical implications
S. Pinho (2015)
A review on nanotized herbal drugs
A S Kumar (2015)
Toxicology perspective of nanopharmaceuticals: a critical review
M A Saiyed (2011)
Priyanshu Verma, 2-32 Public health
Nanopharmaceuticals: Healthcare Applications and Safety Evaluations
18 Penetration enhancement
A Paya-Perez
10.2147/IJN.S33838
Nanotechnology-based approaches in anticancer research
N. Jabir (2012)
10.1016/J.IJPHARM.2004.01.015
Physicochemical characterisation of liposomes with encapsulated local anaesthetics.
M. Müller (2004)
10.1186/1752-0509-2-74
A review of imaging techniques for systems biology
Armen Kherlopian (2008)
10.4103/0975-8453.59514
Biopharmaceutics classification system
H. Chavda (2010)
10.2174/0929867323666161028160855
Phytosomes as Biocompatible Carriers of Natural Drugs.
Diogo Matias (2017)
10.1038/nature17039
Reparative inflammation takes charge of tissue regeneration
M. Karin (2016)
10.1021/bk-1997-0662
Antinutrients and Phytochemicals in Food
F. Shahidi (1997)
10.1016/j.nano.2018.04.013
A theranostic nanocomposite system based on iron oxide-drug nanocages for targeted magnetic field responsive chemotherapy.
M. P. Kesavan (2018)
10.1016/j.jare.2016.03.003
In vitro assessment of pharmaceutical potential of ethosomes entrapped with terbinafine hydrochloride.
Syed Ahmed Iizhar (2016)
10.1021/bm301719b
Paclitaxel-conjugated PAMAM dendrimers adversely affect microtubule structure through two independent modes of action.
Erika N Cline (2013)
10.3109/02652040903367327
Liposomes incorporating essential oil of Brazilian cherry (Eugenia uniflora L.): Characterization of aqueous dispersions and lyophilized formulations
P. Yoshida (2010)
10.1016/j.scitotenv.2012.08.066
The complexity of nanoparticle dissolution and its importance in nanotoxicological studies.
S. Misra (2012)
10.1016/j.jcis.2014.11.056
Magnetocubosomes for the delivery and controlled release of therapeutics.
C. Montis (2015)
10.2147/IJN.S81271
Antimicrobial activity of cream incorporated with silver nanoparticles biosynthesized from Withania somnifera
Gregory Marslin (2015)
10.1016/j.bmc.2009.11.013
Synthesis, nanosizing and in vitro drug release of a novel anti-HIV polymeric prodrug: chitosan-O-isopropyl-5'-O-d4T monophosphate conjugate.
L. Yang (2010)
10.2147/DDDT.S133170
Historical development of vaginal microbicides to prevent sexual transmission of HIV in women: from past failures to future hopes
F. Notario-Pérez (2017)
10.1002/jps.22028
Evaluation of percutaneous absorption of naproxen from different liposomal formulations.
C. Puglia (2010)
10.1016/J.LWT.2012.03.027
Antioxidant and antimicrobial properties of essential oils encapsulated in zein nanoparticles prepared by liquid–liquid dispersion method
Yunpeng Wu (2012)
10.1016/j.jtemb.2016.03.017
Are iron oxide nanoparticles safe? Current knowledge and future perspectives.
Vanessa Valdiglesias (2016)
10.3109/08982104.2015.1098659
Nano-transfersomal formulations for transdermal delivery of asenapine maleate: in vitro and in vivo performance evaluations
A. Shreya (2016)
10.3109/00498258709043943
Transdermal drug delivery and cutaneous metabolism.
R. H. Guy (1987)
10.1111/j.2042-7158.1988.tb05295.x
Non-ionic surfactant effects on hairless mouse skin permeability characteristics.
K. Walters (1988)
10.1016/S0378-5173(03)00366-1
The effect of beta-cyclodextrins on the permeation of diclofenac from supersaturated solutions.
M. Dias (2003)
10.3109/08982100903014994
Span® and Tween® neutral and pH-sensitive vesicles: Characterization and in vitro skin permeation
M. Carafa (2009)
10.1016/j.febslet.2013.11.011
Phage protein‐targeted cancer nanomedicines
V. Petrenko (2014)
10.1021/I360050A010
Isolation of Antitumor Alkaloids from Cephalotaxus harringtonia
R. G. Powell (2002)
10.1097/CAD.0b013e3283534051
Ethogel topical formulation for increasing the local bioavailability of 5-fluorouracil: a mechanistic study
R. Puri (2012)
10.1166/JCSB.2012.1020
Preparation, Characterization and Applications of Liposomes: State of the Art
A. Laouini (2012)
10.22038/AJP.2015.3872
Cancer therapy with phytochemicals: evidence from clinical studies
A. Hosseini (2015)
10.1080/10611860600965914
Poly (propyleneimine) dendrimer based nanocontainers for targeting of efavirenz to human monocytes/macrophages in vitro
T. Dutta (2007)
10.1038/nrd3078
How to improve R&D productivity: the pharmaceutical industry's grand challenge
S. Paul (2010)
10.1111/jphp.12232
In-vitro/in-vivo characterization of trans-resveratrol-loaded nanoparticulate drug delivery system for oral administration.
Gurinder Singh (2014)
10.1186/s13075-016-1025-y
Curcumin slows osteoarthritis progression and relieves osteoarthritis-associated pain symptoms in a post-traumatic osteoarthritis mouse model
Z. Zhang (2016)
10.1016/0005-2736(91)90246-5
Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo.
T. Allen (1991)
10.1021/cn4001582
Alzheimer's disease: pathophysiology and applications of magnetic nanoparticles as MRI theranostic agents.
H. Amiri (2013)
10.2174/1389201053167158
The impact of nanobiotechnology on the development of new drug delivery systems.
O. Kayser (2005)
10.1016/S0168-3659(97)00237-X
Delivery of molecular and cellular medicine to solid tumors.
Jain (1997)
Biochimica et Biophysica Acta targeted delivery of quercetin loaded mesoporous silica nanoparticles to the breast cancer cells
A Sarkar (2016)
10.2174/1874126600701010036
Innovative Strategies for Enhancing Topical and Transdermal Drug Delivery
Desmond I. J. Morrow (2007)
10.1016/j.bbagen.2014.06.004
Combinatorial anticancer effects of curcumin and 5-fluorouracil loaded thiolated chitosan nanoparticles towards colon cancer treatment.
A. Anitha (2014)
HIV compartmentalization: pathogenesis and clinical implications
J R Clarke (2000)
10.4314/AJB.V7I25.59701
Protein nanoparticle: A unique system as drug delivery vehicles
M. Jahanshahi (2008)
10.1016/j.biomaterials.2007.12.037
Particle size-dependent organ distribution of gold nanoparticles after intravenous administration.
W. D. de Jong (2008)
10.1080/08982100902722381
Preparation of matrine ethosome, its percutaneous permeation in vitro and anti-inflammatory activity in vivo in rats
Zeng Zhao-wu (2009)
10.1021/mp9001206
Synthesis and in vivo antitumor efficacy of PEGylated poly(l-lysine) dendrimer-camptothecin conjugates.
Megan E Fox (2009)
10.3389/fmicb.2017.00336
Antifungal Therapy for Systemic Mycosis and the Nanobiotechnology Era: Improving Efficacy, Biodistribution and Toxicity
A. C. Souza (2017)
10.1016/J.MARPOLBUL.2004.03.016
A review of pollutants in the sea-surface microlayer (SML): a unique habitat for marine organisms.
O. Wurl (2004)
10.1016/J.JCONREL.2007.09.010
Dual asymmetric centrifugation (DAC)--a new technique for liposome preparation.
U. Massing (2008)
10.1016/j.chemosphere.2017.05.061
Genotoxic and mutagenic assessment of iron oxide (maghemite-γ-Fe2O3) nanoparticle in the guppy Poecilia reticulata.
G. Qualhato (2017)
10.1081/LPR-120004784
LIPOSOME-ENABLED SYNERGISTIC INTERACTION OF ANTIMICROBIAL AGENTS
R. Schiffelers (2002)
10.1016/S1470-2045(12)70476-X
Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study.
C. Mamot (2012)
10.3109/10837450.2014.882939
Quality by design approach for formulation, evaluation and statistical optimization of diclofenac-loaded ethosomes via transdermal route
S. Jain (2015)
10.1038/jid.1965.140
Mechanism of percutaneous adsorption. I. Routes of penetration and the influence of solubility.
R. Scheuplein (1965)
10.2147/DDDT.S70650
Characterization and in vitro studies of the anticancer effect of oxidized carbon nanotubes functionalized with betulinic acid
J. Tan (2014)
10.1007/s10311-017-0633-3
Applications and genotoxicity of nanomaterials in the food industry
Venkatraman Manickam (2017)
10.2174/1568026615666150414120547
Drug Delivery Systems and Combination Therapy by Using Vinca Alkaloids
Chun-Ting Lee (2015)
10.1006/JSRE.2000.6030
Clinical applications of magnetic drug targeting.
A. Lübbe (2001)
10.1159/000339613
Wound Repair and Regeneration
J. M. Reinke (2012)
10.1016/j.carbpol.2016.10.030
PAMAM-pullulan conjugates as targeted gene carriers for liver cell.
S. Askarian (2017)
10.1016/j.colsurfb.2008.06.016
Oil-in-water lecithin-based microemulsions as a potential delivery system for amphotericin B.
K. C. Pestana (2008)
10.1016/j.jconrel.2014.05.054
Advances in lipid-based colloid systems as drug carrier for topic delivery.
Yingjie Zhai (2014)
10.3892/mmr.2016.4948
Role of neuroinflammation in neurodegenerative diseases (Review)
W. Chen (2016)
10.1016/j.ijantimicag.2016.11.011
Metal oxide nanoparticles as antimicrobial agents: a promise for the future.
A. Raghunath (2017)
10.1016/0005-2736(92)90154-E
Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force.
G. Cevc (1992)
10.1002/JCP.21263
Ajulemic acid, a nonpsychoactive cannabinoid acid, suppresses osteoclastogenesis in mononuclear precursor cells and induces apoptosis in mature osteoclast-like cells.
Kerri L George (2008)
10.1211/JPP.58.2.0002
Skin permeation of retinol in Tween 20-based deformable liposomes: in-vitro evaluation in human skin and keratinocyte models.
Yu-Kyoung Oh (2006)
10.1002/anie.201301135
Multi-chromatic pH-activatable 19F-MRI nanoprobes with binary ON/OFF pH transitions and chemical-shift barcodes.
Xiaonan Huang (2013)
10.1358/DOF.2002.027.09.694498
Milestones in camptothecin research
H. Lerchen (2002)
10.1016/j.ejpb.2016.02.013
Optimization of elastic transfersomes formulations for transdermal delivery of pentoxifylline.
Ahmed H Al Shuwaili (2016)
10.1023/A:1022604120952
Direct Evidence That Polysorbate-80-Coated Poly(Butylcyanoacrylate) Nanoparticles Deliver Drugs to the CNS via Specific Mechanisms Requiring Prior Binding of Drug to the Nanoparticles
J. Kreuter (2004)
10.2147/DDDT.S142337
The new era of nanotechnology, an alternative to change cancer treatment
Ancuța Jurj (2017)
10.1146/annurev-food-030713-092354
Nanodelivery of bioactive components for food applications: types of delivery systems, properties, and their effect on ADME profiles and toxicity of nanoparticles.
T. Borel (2014)
10.1007/s13277-013-1542-0
Genistein exhibits anti-cancer effects via down-regulating FoxM1 in H446 small-cell lung cancer cells
Tiantian Tian (2013)
10.1021/acs.jafc.7b02128
Edible Nanoencapsulation Vehicles for Oral Delivery of Phytochemicals: A Perspective Paper.
J. Xiao (2017)
10.3168/jds.2013-7263
Antiproliferative activity of tea catechins associated with casein micelles, using HT29 colon cancer cells.
S. Haratifar (2014)
10.4155/TDE.10.16
Challenges and opportunities in dermal/transdermal delivery.
Kalpana S. Paudel (2010)
10.1016/j.addr.2012.01.020
Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications.
E. Fleige (2012)
10.1016/J.VIROL.2006.08.012
Laboratory investigations for the morphologic, pharmacokinetic, and anti-retroviral properties of indinavir nanoparticles in human monocyte-derived macrophages.
Huanyu Dou (2007)
10.1080/10717544.2017.1326539
Etodolac transdermal cubosomes for the treatment of rheumatoid arthritis: ex vivo permeation and in vivo pharmacokinetic studies
S. Salah (2017)
10.1208/s12249-012-9871-7
Formulation of Niosomal Gel for Enhanced Transdermal Lopinavir Delivery and Its Comparative Evaluation with Ethosomal Gel
K. K. Patel (2012)
10.1002/jps.23515
A comparative analysis of biopharmaceutics classification system and biopharmaceutics drug disposition classification system: a cross-sectional survey with 500 bioequivalence studies.
R. Cristofoletti (2013)
10.1081/DDC-120025458
Transfersomes—A Novel Vesicular Carrier for Enhanced Transdermal Delivery: Development, Characterization, and Performance Evaluation
S. Jain (2003)
10.1021/BM050802S
Dendrimers: novel polymeric nanoarchitectures for solubility enhancement.
U. Gupta (2006)
10.1016/j.ijpharm.2016.04.011
Effects of permeation enhancers on flufenamic acid delivery in Ex vivo human skin by confocal Raman microscopy.
Yelena Pyatski (2016)
10.7314/APJCP.2015.16.5.1725
Effect of paclitaxel-loaded nanoparticles on the viability of human hepatocellular carcinoma HepG2 cells.
Zhi-hong Hou (2015)
10.1016/J.NANO.2005.12.003
Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles.
C. Reis (2006)
10.1016/j.ijpharm.2017.01.067
Protein-based nanoparticles: From preparation to encapsulation of active molecules.
Mohamad Tarhini (2017)
Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.
A. Bhatia (2004)
10.1016/j.cis.2012.08.002
Niosomes: novel sustained release nonionic stable vesicular systems--an overview.
N. B. Mahale (2012)
10.3109/1061186X.2015.1070855
Nanosized ethosomes-based hydrogel formulations of methoxsalen for enhanced topical delivery against vitiligo: formulation optimization, in vitro evaluation and preclinical assessment
B. Garg (2016)
10.1016/j.biopha.2017.09.059
A review on the efficacy and toxicity of different doxorubicin nanoparticles for targeted therapy in metastatic breast cancer.
A. Shafei (2017)
10.1021/JF040492P
Encapsulation of essential oils in zein nanospherical particles.
N. Parris (2005)
10.3109/10717544.2014.924167
Preparation and in vitro/in vivo evaluation of resveratrol-loaded carboxymethyl chitosan nanoparticles
Y. Zu (2016)
10.2174/1389200218666170201151135
Pancreatic Cancer Therapy Review: From Classic Therapeutic Agents to Modern Nanotechnologies.
Ana Rebelo (2017)
10.1111/J.1365-2125.2007.03065.X
The role of hair follicles in the percutaneous absorption of caffeine.
N. Otberg (2008)
10.1021/ACS.MOLPHARMACEUT.6B00691
Improving Efficacy, Oral Bioavailability, and Delivery of Paclitaxel Using Protein-Grafted Solid Lipid Nanoparticles.
D. Pooja (2016)
10.2174/1389557023405873
Liposomes for intravenous drug targeting: design and applications.
J. Metselaar (2002)
ORGANOGELS : ADVANCED AND NOVEL DRUG DELIVERY SYSTEM
Garg Tarun (2012)
10.1016/j.ijpharm.2017.10.046
Lipid nanocarriers as skin drug delivery systems: Properties, mechanisms of skin interactions and medical applications.
M. Šala (2018)
10.1111/j.1476-5381.2009.00617.x
Poly(lactic acid‐glycolic acid) nanoparticles markedly improve immunological protection provided by peptide P10 against murine paracoccidioidomycosis
A. C. Amaral (2010)
10.1016/j.biortech.2009.02.018
In situ preparation of magnetic Fe3O4-chitosan nanoparticles for lipase immobilization by cross-linking and oxidation in aqueous solution.
Yue Wu (2009)
10.1016/J.JMMM.2009.07.086
Synthesis and characterization of noscapine loaded magnetic polymeric nanoparticles.
M. O. Abdalla (2010)
VESICLES - MECHANISM OF TRANSDERMAL PERMEATION: A REVIEW
P. Lakshmi (2012)
10.1517/17425247.2014.955011
Development of next-generation macromolecular drugs based on the EPR effect: challenges and pitfalls
H. Nakamura (2015)
10.1016/j.ijpharm.2017.04.073
Dendrimer encapsulated and conjugated delivery of berberine: A novel approach mitigating toxicity and improving in vivo pharmacokinetics.
L. Gupta (2017)
10.3389/fimmu.2017.00239
Role of Metallic Nanoparticles in Vaccinology: Implications for Infectious Disease Vaccine Development
Lázaro Moreira Marques Neto (2017)
10.1016/j.carbpol.2013.08.078
Cyclodextrins as encapsulation agents for plant bioactive compounds.
E. Pinho (2014)
10.1021/BC070020R
Surface engineering of quantum dots for in vivo vascular imaging.
A. Jayagopal (2007)
10.1007/s11051-014-2821-4
Dual drug-loaded paclitaxel–thymoquinone nanoparticles for effective breast cancer therapy
P. Soni (2015)
10.1021/JS990154G
Transdermal penetration enhancers: applications, limitations, and potential.
B. Finnin (1999)
10.1007/978-1-4899-1778-2
Phytochemistry of Medicinal Plants
M. Saxena (1995)
10.1016/j.scitotenv.2016.02.003
A review of the environmental implications of in situ remediation by nanoscale zero valent iron (nZVI): Behavior, transport and impacts on microbial communities.
E. Lefèvre (2016)
10.1080/1061186X.2016.1184669
Passive and semi-active targeting of bone marrow and leukemia cells using anionic low cholesterol liposomes
P. Tardi (2016)
10.1016/S0168-3659(99)00248-5
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review.
H. Maeda (2000)
10.1016/J.TRAC.2015.06.014
PLGA-based nanoparticles: A new paradigm in biomedical applications
Shweta R. Sharma (2016)
10.1189/JLB.0205074
Nanotechnology for the biologist.
S. Mcneil (2005)
10.5772/59346
Impact of Silver Nanoparticles on Haemolysis, Platelet Function and Coagulation
J. Laloy (2014)
10.1016/j.ejpb.2010.10.011
Novel sugar esters proniosomes for transdermal delivery of vinpocetine: preclinical and clinical studies.
H. M. El-laithy (2011)
10.1016/j.biomaterials.2017.11.046
DNA nanoparticles for ophthalmic drug delivery.
Jan Willem de Vries (2018)
10.1016/j.fct.2015.06.012
Flow cytometry evaluation of in vitro cellular necrosis and apoptosis induced by silver nanoparticles.
G. Kumar (2015)
10.1186/1556-276X-8-102
Liposome: classification, preparation, and applications
A. Akbarzadeh (2013)
10.1016/j.ejpb.2011.01.011
Skin penetration behaviour of liposomes as a function of their composition.
A. Gillet (2011)
10.1016/S0169-409X(96)00454-1
Role of saccharides for the freeze-thawing and freeze drying of liposome
Koichiro Miyajima (1997)
10.1016/j.ijpharm.2015.02.021
Zirconium phosphatidylcholine-based nanocapsules as an in vivo degradable drug delivery system of MAP30, a momordica anti-HIV protein.
Guo Caizhen (2015)
10.1007/s00280-012-2042-4
Marqibo® (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine
J. Silverman (2012)
10.1208/s12249-008-9124-y
In Vitro Percutaneous Permeation and Skin Accumulation of Finasteride Using Vesicular Ethosomal Carriers
Y. Rao (2008)
10.1016/S0928-0987(01)00167-1
Novel mechanisms and devices to enable successful transdermal drug delivery.
B. Barry (2001)
10.1021/BC049951I
Toxicity of gold nanoparticles functionalized with cationic and anionic side chains.
Catherine M Goodman (2004)
10.1016/J.POLYMER.2010.05.030
Water-soluble heparin–PTX conjugates for cancer targeting
I. Park (2010)
10.1016/j.ijpharm.2010.04.001
A fundamental investigation into the effects of eutectic formation on transmembrane transport.
S. Fiala (2010)
10.1021/cr900174j
Dendrimers as carriers for delivery of chemotherapeutic agents.
S. Medina (2009)
10.1097/00045391-199608000-00012
BURGER'S MEDICINAL CHEMISTRY AND DRUG DISCOVERY
Manfred E. Wolff (1996)
ELASTIC VESICLES AS DRUGS CARRIERS THROUGH THE SKIN
C. Pîrvu (2010)
10.1088/1361-6528/aac7dd
Nanoformulations of doxorubicin: how far have we come and where do we go from here?
I. Borišev (2018)
10.1016/J.MATLET.2014.12.070
Synthesis of highly dispersed nanoscaled CoQ10 liposome by supercritical fluid
Shaohong Xu (2015)
10.1016/J.COLSURFA.2015.04.035
Glycopolymer modified magnetic mesoporous silica nanoparticles for MR imaging and targeted drug delivery
Jinxia An (2015)
10.1088/0957-4484/21/28/285104
Delivery of phytochemical thymoquinone using molecular micelle modified poly(D, L lactide-co-glycolide) (PLGA) nanoparticles.
G. Ganea (2010)
10.1016/J.IFSET.2013.03.002
Nanostructured lipid carriers (NLC): A potential delivery system for bioactive food molecules
F. Tamjidi (2013)
10.1208/s12248-014-9688-2
Physicochemical and Formulation Developability Assessment for Therapeutic Peptide Delivery—A Primer
Annette Bak (2014)
10.1371/journal.pmed.1000321
The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial
R. Gandhi (2010)
10.1089/107555303321223035
Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa).
N. Chainani-Wu (2003)
10.1016/j.ejps.2017.11.029
Controlled‐release biodegradable nanoparticles: From preparation to vaginal applications
Beatriz Martínez-Pérez (2018)
10.1016/S0168-3659(99)00245-X
Water-soluble dendritic unimolecular micelles: their potential as drug delivery agents.
M. Liu (2000)
10.1016/J.PROGPOLYMSCI.2007.05.009
Physical stimuli-responsive polymeric micelles for anti-cancer drug delivery
N. Rapoport (2007)
10.1016/j.ijbiomac.2017.05.127
Chitosan stabilized camptothecin nanoemulsions: Development, evaluation and biodistribution in preclinical breast cancer animal mode.
Subramanian Natesan (2017)
10.1007/BF00575063
Arglabin — A new sesquiterpene lactone fromArtemisia glabella
S. Adekenov (2004)
10.1096/fj.04-2747rev
Nanomedicine: current status and future prospects
S. Moghimi (2005)
10.1007/978-3-0348-9006-9_10
Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine.
L. F. Brown (1997)
10.1155/2013/627375
New Perspectives on How to Discover Drugs from Herbal Medicines: CAM's Outstanding Contribution to Modern Therapeutics
Si-Yuan Pan (2013)
10.1016/J.JCONREL.2004.09.023
Targeting tumor angiogenic vasculature using polymer-RGD conjugates.
A. Mitra (2005)
10.1080/10408390903584094
Effects of Flavonoids and other Polyphenols on Inflammation
R. González (2011)
10.2147/IJN.S46958
Novel intravaginal nanomedicine for the targeted delivery of saquinavir to CD4+ immune cells
Sidi Yang (2013)
10.1002/cncr.22035
Emerging implications of nanotechnology on cancer diagnostics and therapeutics
A. Cuenca (2006)
10.1016/J.CARBPOL.2009.12.040
Preparation of poly(lactic acid)/chitosan nanoparticles for anti-HIV drug delivery applications
Ashish Dev (2010)
10.1016/j.jconrel.2008.11.029
Preparation of small amounts of sterile siRNA-liposomes with high entrapping efficiency by dual asymmetric centrifugation (DAC).
Markus Hirsch (2009)
10.1093/TOXSCI/KFJ014
A physiologically based pharmacokinetic model of organophosphate dermal absorption.
D. van der Merwe (2006)
10.1007/s10856-015-5618-9
Application of albumin-based nanoparticles in the management of cancer
Xinzhe Yu (2015)
10.1039/C1PY00061F
Polymeric vesicles in biomedical applications
René P. Brinkhuis (2011)
10.3109/03639049309047198
Topical Liposomal local Anesthetics: Design, Optimization and Evaluation of Formulations
M. Foldvari (1993)
10.1016/j.toxlet.2017.05.007
Toxicity of silver nanoparticles in biological systems: Does the complexity of biological systems matter?
R. Vazquez-Muñoz (2017)
10.3109/10717544.2014.932862
Preparation, characterization and in vitro activities evaluation of solid lipid nanoparticles based on PEG-40 stearate for antifungal drugs vaginal delivery
R. Cassano (2016)
10.1517/17425247.2013.746310
Niosomes as a propitious carrier for topical drug delivery
H. Hamishehkar (2013)
10.1016/j.colsurfb.2016.08.002
PEGylated Polyamidoamine dendrimer conjugated with tumor homing peptide as a potential targeted delivery system for glioma.
Y. Jiang (2016)
10.1080/17425247.2016.1244187
Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures
Héloïse Ragelle (2017)
10.1016/j.ijpharm.2016.09.038
Transdermal iontophoretic delivery of tacrine hydrochloride: Correlation between in vitro permeation and in vivo performance in rats.
N. Patel (2016)
10.1016/S1386-6532(00)00165-7
Progress in understanding cytomegalovirus drug resistance.
V. Emery (2001)
10.1021/acs.est.5b00302
Improving environmental risk assessment of human pharmaceuticals.
M. Ågerstrand (2015)
10.1038/sj.ejcn.1602733
Effects of plant sterol and stanol ester consumption on lipid metabolism, antioxidant status and markers of oxidative stress, endothelial function and low-grade inflammation in patients on current statin treatment
A. D. Jong (2008)
10.1007/s11095-008-9800-3
Methods for the Preparation and Manufacture of Polymeric Nanoparticles
C. Vauthier (2008)
10.1016/S0005-2736(97)00056-4
Immunogenicity and pharmacokinetic attributes of poly(ethylene glycol)-grafted immunoliposomes.
J. A. Harding (1997)
10.1152/ajpheart.1992.262.1.H246
gp60 is an albumin-binding glycoprotein expressed by continuous endothelium involved in albumin transcytosis.
J. Schnitzer (1992)
Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells.
M. Masuda (2003)
10.1002/1520-6017(200105)90:5<607::AID-JPS1017>3.0.CO;2-B
Permeation enhancement of a highly lipophilic drug using supersaturated systems.
K. Moser (2001)
10.1007/s10118-013-1331-7
Biopolymer based nano-delivery systems for enhancing bioavailability of nutraceuticals
Bing Hu (2013)
10.1021/ar300069t
Ecological nanotoxicology: integrating nanomaterial hazard considerations across the subcellular, population, community, and ecosystems levels.
P. Holden (2013)
10.1016/S0169-409X(99)00027-7
Oral absorption of the HIV protease inhibitors: a current update.
Williams (1999)
10.1080/10717544.2016.1228718
Skin delivery of epigallocatechin-3-gallate (EGCG) and hyaluronic acid loaded nano-transfersomes for antioxidant and anti-aging effects in UV radiation induced skin damage
K. Avadhani (2017)
10.1211/0022357991776813
Skin delivery of oestradiol from deformable and traditional liposomes: mechanistic studies.
G. E. El Maghraby (1999)
10.1186/1477-3155-9-44
Formation and stability of oil-in-water nanoemulsions containing rice bran oil: in vitro and in vivo assessments
D. S. Bernardi (2011)
10.4155/tde.14.32
Ultrasound-enhanced transdermal delivery: recent advances and future challenges.
Matthias Oberli (2014)
10.1016/j.phrs.2010.01.009
Nanopharmacy: Inorganic nanoscale devices as vectors and active compounds.
Pilar Rivera Gil (2010)
10.1016/J.IJPHARM.2006.12.048
Immuno-targeting of nonionic surfactant vesicles to inflammation.
E. Hood (2007)
10.3390/md15030060
Chitosan-Based Multifunctional Platforms for Local Delivery of Therapeutics
Seong-Chul Hong (2017)
10.1615/CRITREVTHERDRUGCARRIERSYST.V20.I1.20
Ethosomes: new prospects in transdermal delivery.
B. Godin (2003)
10.1016/j.colsurfb.2014.02.036
Storage stability and skin permeation of vitamin C liposomes improved by pectin coating.
W. Zhou (2014)
10.1016/J.AJPS.2013.07.015
Folic acid-conjugated liposomal vincristine for multidrug resistant cancer therapy
C. Wang (2013)
10.1016/j.carbpol.2013.01.091
Construction of hyaluronic acid noisome as functional transdermal nanocarrier for tumor therapy.
M. Kong (2013)
10.1023/A:1026166729873
Engineering of Dendrimer Surfaces to Enhance Transepithelial Transport and Reduce Cytotoxicity
R. Jevprasesphant (2004)
10.1016/j.cis.2013.11.018
Niosomes from 80s to present: the state of the art.
C. Marianecci (2014)
10.1021/es2023225
Commercial titanium dioxide nanoparticles in both natural and synthetic water: comprehensive multidimensional testing and prediction of aggregation behavior.
S. Ottofuelling (2011)
10.1038/nnano.2007.387
Nanocarriers as an emerging platform for cancer therapy.
D. Peer (2007)
Radionuclide imaging of tumor xenografts in mice using a gelatinase-targeting peptide.
O. Medina (2005)
Magnetochemotherapy for cervical cancer treatment with camptothecin loaded Fe 3 O 4 functionalized b-cyclodextrin nanovehicle
M Rajan (2017)
10.1016/S0001-8686(03)00109-X
Rational design and engineering of delivery systems for therapeutics: biomedical exercises in colloid and surface science.
K. Kostarelos (2003)
10.1016/j.jconrel.2017.03.029
Intranasal delivery of N‐terminal modified leptin‐pluronic conjugate for treatment of obesity
Dongfen Yuan (2017)
10.1039/C2EM30640A
Potential environmental implications of nano-enabled medical applications: critical review.
Indrani Mahapatra (2013)
10.1070/RC2012V081N01ABEH004219
Nanoemulsions: the properties, methods of preparation and promising applications
M. Koroleva (2012)
10.1016/J.IJPHARM.2005.09.023
Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide.
Ahmed S. Guinedi (2005)
10.1002/jps.21944
Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery.
Z. S. Bayindir (2010)
10.1016/j.vaccine.2009.05.029
Eleven years of Inflexal V-a virosomal adjuvanted influenza vaccine.
C. Herzog (2009)
10.1002/jps.2600750403
Characterization of proliposomes.
N. Payne (1986)
10.1016/0021-9797(88)90181-6
The spontaneous formation of unilamellar vesiscles
Danil D Lasic (1988)
10.1016/j.ijpharm.2010.11.003
Proniosomes as a carrier system for transdermal delivery of tenoxicam.
H. Ammar (2011)
Enhanced Permeability and Retention ( EPR ) Effect Based Tumor Targeting : The Concept , Application and Prospect
H. Yin (2014)
10.1016/J.INDCROP.2014.12.031
In vivo antifungal activity of two essential oils from Mediterranean plants against postharvest brown rot disease of peach fruit
H. S. Elshafie (2015)
10.1016/j.jare.2016.07.003
Improved bioavailability of timolol maleate via transdermal transfersomal gel: Statistical optimization, characterization, and pharmacokinetic assessment
N. Morsi (2016)
10.3389/fphar.2018.00790
Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization
Susan Hua (2018)
APPLICATION OF CHITOSAN MICROSPHERES AS DRUG CARRIERS : A REVIEW
Rahul S. Nair (2009)
10.3109/13880209.2010.528432
Transdermal absorption enhancement of gel containing elastic niosomes loaded with gallic acid from Terminalia chebula galls
A. Manosroi (2011)
10.1517/17425255.2015.992781
Safety and toxicity concerns of orally delivered nanoparticles as drug carriers
F. Araújo (2015)
10.1002/pmic.201300387
Cell surface protein glycosylation in cancer.
M. N. Christiansen (2014)
10.12980/APJTB.4.2014C980
Nanotechnology: an effective tool for enhancing bioavailability and bioactivity of phytomedicine.
T. Gunasekaran (2014)
10.1016/j.ijpharm.2008.04.033
Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac diethylammonium.
A. Manosroi (2008)
10.1016/j.nano.2011.07.011
Curcumin-loaded γ-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma.
S. Dhule (2012)
10.1016/j.envint.2016.09.021
Environmental behaviour and ecotoxicity of quantum dots at various trophic levels: A review.
T. Rocha (2017)
10.3109/10717544.2014.935532
Permeation enhancer strategies in transdermal drug delivery
Harneet Marwah (2016)
10.1007/s11051-016-3517-8
Uptake, delivery, and anticancer activity of thymoquinone nanoparticles in breast cancer cells
Isabelle Fakhoury (2016)
10.1186/s13065-018-0434-1
Enhancement of oral bioavailability of doxorubicin through surface modified biodegradable polymeric nanoparticles
N. Ahmad (2018)
10.1016/j.ijpharm.2011.11.035
Lipomer of doxorubicin hydrochloride for enhanced oral bioavailability.
Derajram M Benival (2012)
10.1002/jps.23359
The role of BCS (biopharmaceutics classification system) and BDDCS (biopharmaceutics drug disposition classification system) in drug development.
L. Benet (2013)
10.1016/J.INDCROP.2016.01.007
A new biodegradable polymeric nanoparticle formulation containing Syzygium cumini: Phytochemical profile, antioxidant and antifungal activity and in vivo toxicity
P. R. Bitencourt (2016)
10.1016/j.fct.2012.11.004
Antitumor effect and toxicity of Lipusu in rat ovarian cancer xenografts.
Liang Ye (2013)
10.4067/S0718-27242013000200009
Patents, Drug Delivery and Public Health Protection: Health Risk Management for Nanopharmaceuticals
L. Sant'Anna (2013)
Production, characterization, in vitro and ex vivo studies of babchi oil-encapsulated nanostructured solid lipid carriers produced by a hot aqueous titration method.
M. Faiyazuddin (2010)
10.1039/c4em00551a
Toxic effects of copper-based nanoparticles or compounds to lettuce (Lactuca sativa) and alfalfa (Medicago sativa).
J. Hong (2015)
10.1016/j.colsurfb.2013.08.038
Alginate/cashew gum nanoparticles for essential oil encapsulation.
Erick F de Oliveira (2014)
10.1042/bj1860591
Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro.
C. Kirby (1980)
10.1016/j.biomaterials.2017.10.023
Creation of a nanoformulated cabotegravir prodrug with improved antiretroviral profiles
Tian Zhou (2018)
10.1097/01.CAD.0000167902.53039.5A
Liposomal encapsulated anti-cancer drugs.
R. Hofheinz (2005)
10.1016/j.ejpb.2014.04.009
Co-encapsulation of resveratrol and curcumin in lipid-core nanocapsules improves their in vitro antioxidant effects.
K. Coradini (2014)
Effect Of Cholesterol Content And Surfactant HLB On Vesicle Properties Of Niosomes
S. Agarwal (2004)
10.3390/ma10080929
Smart Carriers and Nanohealers: A Nanomedical Insight on Natural Polymers
S. Raveendran (2017)
10.1016/J.PROGPOLYMSCI.2011.01.001
Polymer nanoparticles: Preparation techniques and size-control parameters
J. D. Rao (2011)
10.1007/S11051-009-9692-0
Analysis of the toxicity of gold nano particles on the immune system: effect on dendritic cell functions
C. Villiers (2010)
10.3329/ICPJ.V1I11.12063
Development of ethosomes with taguchi robust design-based studies for transdermal delivery of alfuzosin hydrochloride
D. Prasanthi (2012)
10.2174/1389203711209070632
Nanobiotechnology: an efficient approach to drug delivery of unstable biomolecules.
A. C. Amaral (2013)
10.1007/978-3-662-45013-0
Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement
Nina Dragicevic (2015)
10.2217/nnm.13.90
Biphasic magnetic nanoparticles-nanovesicle hybrids for chemotherapy and self-controlled hyperthermia.
Manashjit Gogoi (2014)
10.1016/j.addr.2008.03.015
Bioconjugated quantum dots for in vivo molecular and cellular imaging.
A. Smith (2008)
10.3109/10717544.2015.1013200
Transdermal delivery of vancomycin hydrochloride using combination of nano-ethosomes and iontophoresis: in vitro and in vivo study
Magdy I Mohammed (2016)
10.1073/PNAS.95.8.4607
Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment.
S. Hobbs (1998)
Tumor-targeted nanomedicines: principles and practice
T Lammers (2008)
Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2021
© The
WHO Drug Information (2016) A framework for risk-based identification of essential medicine products for local manufacturing in low-and middle-income countries
X Wang (2016)
10.1016/j.chemphyslip.2009.08.003
Ultrasound, liposomes, and drug delivery: principles for using ultrasound to control the release of drugs from liposomes.
Avi Schroeder (2009)
10.1093/ANNONC/MDL104
Abraxane, a novel Cremophor-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer.
M. Green (2006)
10.1080/10934529.2015.975042
Synthesis, morphology and antifungal activity of nano-particulated amphotericin-B, ketoconazole and thymoquinone against Candida albicans yeasts and Candida biofilm
Mohammad A. Randhawa (2015)
10.1155/2014/574673
Lipid Based Vesicular Drug Delivery Systems
S. Jain (2014)
10.1016/j.thromres.2014.05.009
In vitro and in vivo analysis of the antithrombotic and toxicological profile of new antiplatelets N-acylhydrazone derivatives and development of nanosystems: determination of novel NAH derivatives antiplatelet and nanotechnological approach.
Plínio C. Sathler (2014)
10.1023/A:1012128907225
Chitosan and Chitosan/Ethylene Oxide-Propylene Oxide Block Copolymer Nanoparticles as Novel Carriers for Proteins and Vaccines
P. Calvo (2004)
10.2147/IJN.S123437
Nanomedicine applications in the treatment of breast cancer: current state of the art
D. Wu (2017)
10.1007/s13205-014-0214-0
Nanoemulsion: an advanced mode of drug delivery system
Manjit Jaiswal (2014)
10.1016/j.phymed.2015.06.013
The abietane diterpenoid parvifloron D from Plectranthus ecklonii is a potent apoptotic inducer in human leukemia cells.
O. Burmistrova (2015)
10.1002/SMLL.200400093
Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity.
E. E. Connor (2005)
10.1371/journal.pone.0108112
Antiinflammatory Effect of Phytosterols in Experimental Murine Colitis Model: Prevention, Induction, Remission Study
R. Aldini (2014)
10.5681/apb.2014.062
Herbal medicine as inducers of apoptosis in cancer treatment.
E. Safarzadeh (2014)
10.1021/BM0506142
PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality.
I. Majoros (2006)
10.1016/S0378-5173(03)00225-4
Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers.
P. Kolhe (2003)
10.1016/0168-3659(94)00114-A
Proliposomes as an intranasal dosage form for the sustained delivery of propranolol
Byung-Nak Ahn (1995)
10.1155/2007/76087
Clinical Potential of Quantum Dots
A. M. Iga (2007)
10.1016/J.AJPS.2014.09.004
A review on phospholipids and their main applications in drug delivery systems
Jing Li (2015)
10.1159/000086666
Liposomes and Niosomes as Topical Drug Delivery Systems
M. J. Choi (2005)
10.1111/bju.13590
Nanotechnology combined therapy: tyrosine kinase‐bound gold nanorod and laser thermal ablation produce a synergistic higher treatment response of renal cell carcinoma in a murine model
J. Liu (2017)
10.1038/nnano.2009.202
A novel magnetic crystal-lipid nanostructure for magnetically guided in vivo gene delivery.
Y. Namiki (2009)
Long-circulating and target-specific nanoparticles: theory to practice.
S. Moghimi (2001)
10.1016/J.IJPHARM.2007.07.026
Injectable block copolymer hydrogels for sustained release of a PEGylated drug.
Lin Yu (2008)
10.1007/s10103-009-0740-x
Zinc phthalocyanine-loaded PLGA biodegradable nanoparticles for photodynamic therapy in tumor-bearing mice
M. Fadel (2009)
10.1007/s00396-017-4163-0
Adsorption and desorption of curcumin by poly(vinyl) alcohol-multiwalled carbon nanotubes (PVA-MWCNT)
Nurliyana Ahmad Zawawi (2017)
10.1080/10717540500176910
Testosterone Ethosomes for Enhanced Transdermal Delivery
D. Ainbinder (2005)
[Pharmacological and pharmaceutical foundation of nanodrugs].
I. Chekman (2010)
10.1179/joc.2011.23.2.59
Albumin-Bound Paclitaxel: The Benefit of This New Formulation in the Treatment of Various Cancers
M. Montana (2011)
10.1016/J.LIMNO.2016.09.007
Protective effects of chitosan against the hazardous effects of zinc oxide nanoparticle in freshwater crustaceans Ceriodaphnia cornuta and Moina micrura
S. Vijayakumar (2016)
10.2174/1389200218666170306103101
Nanosystems for Skin Delivery: From Drugs to Cosmetics.
A. F. Antunes (2017)
10.1211/JPP.58.4.0005
Ethinylestradiol-loaded ultraflexible liposomes: pharmacokinetics and pharmacodynamics.
M. Garg (2006)
10.4103/0975-8453.86290
Ufasomes: A vesicular drug delivery
Dasharath M. Patel (2011)
10.1586/14737159.3.2.153
Nanodiagnostics: application of nanotechnology in molecular diagnostics
K. Jain (2003)
10.1016/S0167-6296(02)00126-1
The price of innovation: new estimates of drug development costs.
J. DiMasi (2003)
Cationic niosomes as gene carriers: preparation and cellular uptake in vitro.
Y. Z. Huang (2005)
10.2174/138955712801264774
Nanostructures as promising tools for delivery of antimicrobial peptides.
A. Brandelli (2012)
10.1016/J.PLIPRES.2004.12.001
Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release.
T. Andresen (2005)
Applications of pectin: a multipurpose biomolecule
K Muruci De Paula (2016)
The Project on Emerging Nanotechnologies. Health and fitness
(2010)
10.1021/bc900208t
Thiol-modified chitosan sulfate nanoparticles for protection and release of basic fibroblast growth factor.
Yi-Cheng Ho (2010)
10.1002/aic.690210522
Drug permeation through human skin: Theory and invitro experimental measurement
A. Michaels (1975)
10.1038/nrc1566
Cancer nanotechnology: opportunities and challenges
M. Ferrari (2005)
10.1038/nnano.2009.157
Transfer of gold nanoparticles from the water column to the estuarine food web.
J. Ferry (2009)
10.1021/acsnano.8b00940
Prostate-Specific Membrane Antigen Targeted Gold Nanoparticles for Theranostics of Prostate Cancer.
J. Mangadlao (2018)
10.1080/21691401.2017.1396221
Development and evaluation of finasteride loaded ethosomes for targeting to the pilosebaceous unit
V. Wilson (2018)
10.1016/j.ejpb.2015.03.020
Nanoencapsulation of rice bran oil increases its protective effects against UVB radiation-induced skin injury in mice.
L. A. Rigo (2015)
10.1016/0304-4165(78)90240-4
Comparison of large unilamellar vesicles prepared by a petroleum ether vaporization method with multilamellar vesicles: ESR, diffusion and entrapment analyses.
H. Schieren (1978)
10.1111/j.1476-5381.2009.00271.x
Therapeutic action and underlying mechanisms of a combination of two pentacyclic triterpenes, α‐ and β‐amyrin, in a mouse model of colitis
C. E. Vitor (2009)
10.1007/BF02636909
Phase behavior of aqueous systems of monoglycerides
E. S. Lutton (1965)
10.5772/34156
Polysaccharide-Based Nanoparticles for Controlled Release Formulations
A. Martínez (2012)
Drug delivery and targeting, v, 77-107 Drug targeting
10.2217/NNM.13.159
Hydrogel nanoparticles for drug delivery.
M. Dalby (2013)
10.1080/10717544.2017.1410262
Penetration enhancer-containing spanlastics (PECSs) for transdermal delivery of haloperidol: in vitro characterization, ex vivo permeation and in vivo biodistribution studies
A. M. Fahmy (2018)
10.1002/jps.21347
Nanoparticulate biopolymers deliver insulin orally eliciting pharmacological response.
C. Reis (2008)
10.37285/ijpsn.2008.1.1.1
Vesicles of Non-ionic Surfactants ( Niosomes ) and Drug Delivery Potential
S. Biswal (2008)
10.1016/S0378-5173(99)00122-2
Proniosomes: a novel drug carrier preparation.
C. Hu (2000)
10.1155/2013/680580
Ufasomes Mediated Cutaneous Delivery of Dexamethasone: Formulation and Evaluation of Anti-Inflammatory Activity by Carrageenin-Induced Rat Paw Edema Model
Rajkamal Mittal (2013)
10.1016/S0168-3659(03)00200-1
Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin.
A. Chauhan (2003)
10.1016/j.addr.2010.07.009
Nanoparticle-based theranostic agents.
J. Xie (2010)
10.1016/j.jfda.2014.01.005
Mechanisms of nanotoxicity: generation of reactive oxygen species.
P. Fu (2014)
10.1002/jps.2600750402
Proliposomes: a novel solution to an old problem.
N. Payne (1986)
10.1088/2043-6254/AA7716
Application of gold nanoparticles for improved drug efficiency
K. Shittu (2017)
Hormonal therapy of cancer.
A. Segaloff (1959)
10.1016/j.addr.2012.10.003
Advanced materials and processing for drug delivery: the past and the future.
Y. Zhang (2013)
10.1016/j.bbadis.2014.11.004
Resveratrol and cancer: Challenges for clinical translation.
Chandra K Singh (2015)
10.1016/j.ijpharm.2016.01.017
Transdermal glimepiride delivery system based on optimized ethosomal nano-vesicles: Preparation, characterization, in vitro, ex vivo and clinical evaluation.
T. Ahmed (2016)
10.5402/2012/873653
Formulation and In Vitro Evaluation of Ufasomes for Dermal Administration of Methotrexate
A. Sharma (2012)
10.4155/tde.12.143
Drug carriers for oral delivery of peptides and proteins: accomplishments and future perspectives.
Catarina P Reis (2013)
10.1016/j.ijpharm.2011.09.006
Dual targeting folate-conjugated hyaluronic acid polymeric micelles for paclitaxel delivery.
Y. Liu (2011)
10.1016/j.biomaterials.2008.04.038
The effect of surface functionality on cellular trafficking of dendrimers.
Omathanu P Perumal (2008)
10.3390/ijms141121266
Magnetic Nanoparticles: Surface Effects and Properties Related to Biomedicine Applications
B. Issa (2013)
10.1002/SMLL.200600427
Gum arabic as a phytochemical construct for the stabilization of gold nanoparticles: in vivo pharmacokinetics and X-ray-contrast-imaging studies.
Vijaya Kattumuri (2007)
10.1021/jf2050137
Resveratrol nanoparticle system improves dissolution properties and enhances the hepatoprotective effect of resveratrol through antioxidant and anti-inflammatory pathways.
Chiang-Wen Lee (2012)
10.1248/cpb.c17-00447
Gelation Factors of Pectin for Development of a Powder Form of Gel, Dry Jelly, as a Novel Dosage Form.
Yukari Kakino (2017)
10.1186/1743-8977-2-8
Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy
G. Oberdörster (2005)
10.1016/j.ijpharm.2017.07.078
Broad overview of engineering of functional nanosystems for skin delivery.
Ana Henriques Mota (2017)
10.1016/0014-5793(90)81016-H
Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes
A. Klibanov (1990)
10.2147/DDDT.S86370
Characterization of cubosomes as a targeted and sustained transdermal delivery system for capsaicin
X. Peng (2015)
10.15406/jnmr.2016.03.00071
Hollow Magnetic Iron Oxide Nanoparticles as Sodium Meclofenamate Drug Delivery Systems
Vargas-González Brigido Alan (2016)
10.1080/03639045.2016.1181646
Application of design of experiments for formulation development and mechanistic evaluation of iontophoretic tacrine hydrochloride delivery
N. Patel (2016)
10.1517/17425247.3.4.463
The performance of nanocarriers for transmucosal drug delivery
N. Csaba (2006)
10.1016/j.ijpharm.2013.08.019
Nano-lipoidal carriers of tretinoin with enhanced percutaneous absorption, photostability, biocompatibility and anti-psoriatic activity.
K. Raza (2013)
10.1002/wnan.1465
Promise and peril in nanomedicine: the challenges and needs for integrated systems biology approaches to define health risk
S. Halappanavar (2018)
10.18632/oncotarget.11442
CK2 targeted RNAi therapeutic delivered via malignant cell-directed tenfibgen nanocapsule: dose and molecular mechanisms of response in xenograft prostate tumors
K. Ahmed (2016)
10.1371/journal.pone.0046286
Toxicity Assessment of Iron Oxide Nanoparticles in Zebrafish (Danio rerio) Early Life Stages
Xiaoshan Zhu (2012)
10.1021/LA051654U
Preparation of liposomes using an improved supercritical reverse phase evaporation method.
K. Otake (2006)
10.1046/J.1469-7580.2002.00059.X
Endothelial barriers: from hypothetical pores to membrane proteins.
J. A. Firth (2002)
10.1021/jm1013715
Targeted biocompatible nanoparticles for the delivery of (-)-epigallocatechin 3-gallate to prostate cancer cells.
V. Sanna (2011)
10.1016/j.colsurfb.2013.12.009
Development and characterization of two nano-structured systems for topical application of flavanones isolated from Eysenhardtia platycarpa.
Valeri Domínguez-Villegas (2014)
10.2174/1381612823666170124111142
Bile Salt Stabilized Vesicles (Bilosomes): A Novel Nano-Pharmaceutical Design for Oral Delivery of Proteins and Peptides.
J. Ahmad (2017)
10.1080/08982104.2016.1239636
Enhanced skin deposition and delivery of voriconazole using ethosomal preparations
W. Faisal (2018)
10.1088/0031-9155/55/19/023
Characterization of single-core magnetite nanoparticles for magnetic imaging by SQUID relaxometry.
N. Adolphi (2010)
10.2174/22103031113036660015
Liposomes: Targeted and Controlled Delivery System
T. Goyal (2014)
10.1021/acsnano.6b06040
Diverse Applications of Nanomedicine
B. Pelaz (2017)
10.1016/j.addr.2010.10.008
PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect.
Sarbari Acharya (2011)
10.1007/BF02442596
Chitosan-dextran sulfate nanoparticles for delivery of an anti-angiogenesis peptide
Y. Chen (2006)
10.1016/S0168-3659(97)00073-4
In vitro skin permeation of nicotine from proliposomes
B. Hwang (1997)
10.1016/J.COLSURFA.2017.12.070
Surface activity and safety of deamidated zein peptides
Lijuan Zhou (2018)
10.1016/j.jconrel.2012.03.020
Doxil®--the first FDA-approved nano-drug: lessons learned.
Y. Barenholz (2012)
10.1002/JPS.21079
Dendrimers as drug carriers: applications in different routes of drug administration.
Y. Cheng (2008)
10.19277/bbr.12.2.119
Plectranthus madagascariensis phytosomes : formulation optimization
Diogo Matias (2015)
10.1126/science.1230720
Anti-Inflammatory Therapy in Chronic Disease: Challenges and Opportunities
I. Tabas (2013)
10.1016/J.FOODRES.2016.03.031
Nanodelivery systems based on mucoadhesive polymer coated solid lipid nanoparticles to improve the oral intake of food curcumin
P. Ramalingam (2016)
10.1111/j.2042-7158.1985.tb05051.x
The effect of non-ionic surfactant vesicle (niosome) entrapment on the absorption and distribution of methotrexate in mice.
M. N. Azmin (1985)
10.1038/ni.3049
The immunology of asthma
B. Lambrecht (2014)
Questions and answers on Guideline on the environmental risk assessment of medicinal products for human use
London Uk (2011)
61 Natural products, v, 45
S Natesan
Polymeric Nanoparticles 337
10.1002/cncr.21300
Liposome‐encapsulated curcumin
L. Li (2005)
10.1016/J.PROCBIO.2012.12.013
Biologically synthesized green silver nanoparticles from leaf extract of Vitex negundo L. induce growth-inhibitory effect on human colon cancer cell line HCT15
D. Prabhu (2013)
10.1016/j.ecoenv.2008.09.027
Effects of waterborne nano-iron on medaka (Oryzias latipes): antioxidant enzymatic activity, lipid peroxidation and histopathology.
H. Li (2009)
10.1007/978-3-319-41129-3
Natural Polymer Drug Delivery Systems: Nanoparticles, Plants, and Algae
Saurabh Bhatia (2016)
10.2174/1381612823666170407162725
More than Just Size: Challenges and Opportunities of Hybrid Dendritic Nanocarriers.
G. N. Rimondino (2017)
10.1007/978-1-4939-3112-5_11
Dendrimer Nanovectors for SiRNA Delivery.
Xiaoxuan Liu (2016)
Drug Delivery System in Nano Greens
M. Padmavathi (2013)
10.1016/J.COCIS.2007.05.005
Fatty acid vesicles
K. Morigaki (2007)
10.1016/J.ULTRAS.2003.11.011
Development and characterization of a nano-scale contrast agent.
Brian E. Oeffinger (2004)
10.4103/0975-7406.72127
Introduction to metallic nanoparticles
V. Mody (2010)
10.1016/j.ijpharm.2013.01.011
Enhanced transdermal delivery of an anti-hypertensive agent via nanoethosomes: statistical optimization, characterization and pharmacokinetic assessment.
A. Ahad (2013)
10.1517/17425247.2014.890588
Optimized PLGA nanoparticle platform for orally dosed trans-resveratrol with enhanced bioavailability potential
Gurinder Singh (2014)
10.1155/2012/145380
Antioxidant effects of quercetin and catechin encapsulated into PLGA nanoparticles
H. Pool (2012)
10.1155/2014/424239
Novel Resveratrol and 5-Fluorouracil Coencapsulated in PEGylated Nanoliposomes Improve Chemotherapeutic Efficacy of Combination against Head and Neck Squamous Cell Carcinoma
A. Mohan (2014)
10.7324/JAPS.2015.50704
Formulation and in vitro evaluation of berberine containing liposome optimized by 32 full factorial designs
G. Sailor (2015)
10.1016/J.IJPHARM.2005.02.021
Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes.
J. López-Pinto (2005)
10.1002/(SICI)1099-0518(19990901)37:17<3492::AID-POLA7>3.0.CO;2-0
Water-soluble dendrimer-poly(ethylene glycol) starlike conjugates as potential drug carriers
Mingjun Liu (1999)
10.1038/354056a0
Helical microtubules of graphitic carbon
S. Iijima (1991)
10.1016/j.ddtec.2005.05.003
Vesicles as a tool for transdermal and dermal delivery.
P. Honeywell-Nguyen (2005)
10.7555/JBR.28.20130096
Evaluation of metal nanoparticles for drug delivery systems
O. Adeyemi (2015)
10.1186/s12935-016-0287-4
Solamargine triggers cellular necrosis selectively in different types of human melanoma cancer cells through extrinsic lysosomal mitochondrial death pathway
Sana S. Al Sinani (2016)
10.1016/S0378-5173(00)00603-7
Penetration enhancement of ibuprofen from supersaturated solutions through human skin.
M. Iervolino (2001)
10.1371/journal.pone.0131429
Abraxane, the Nanoparticle Formulation of Paclitaxel Can Induce Drug Resistance by Up-Regulation of P-gp
Minzhi Zhao (2015)
10.3390/nu8050307
Epigallocatechin Gallate Nanodelivery Systems for Cancer Therapy
Andreia Granja (2016)
10.1083/jcb.65.1.180
The permeability barrier in mammalian epidermis
P. Elias (1975)
10.1016/J.COPBIO.2005.10.009
Nanotechnology for drug and gene therapy: the importance of understanding molecular mechanisms of delivery.
V. Labhasetwar (2005)
10.1155/2017/8310979
Ethosomes of Phenylethyl Resorcinol as Vesicular Delivery System for Skin Lightening Applications
T. Limsuwan (2017)
10.1016/S0378-5173(98)00006-4
Lipophilic drug derivatives in liposomes
Monica Gulati (1998)
10.1073/pnas.1232410100
Suppression of macrophage inflammatory responses by PPARs
P. Henson (2003)
10.1002/JPS.20098
Current methods for attaching targeting ligands to liposomes and nanoparticles.
Leila Nobs (2004)
10.1016/S0142-9612(00)00063-6
Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes.
N. Dayan (2000)
10.1586/14760584.2014.862500
Transfollicular delivery takes root: the future for vaccine design?
S. Hansen (2014)
10.1007/s40265-016-0538-7
Liposomal Amphotericin B (AmBisome®): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions
N. Stone (2016)
10.1186/s11671-016-1712-2
Graphene Oxide-Gallic Acid Nanodelivery System for Cancer Therapy
Dena Dorniani (2016)
10.1016/0378-5173(94)90178-3
The influence of particle size of liposomes on the deposition of drug into skin
J. D. Plessis (1994)
10.3109/10717544.2014.945130
Enhanced transdermal delivery of luteolin via non-ionic surfactant-based vesicle: quality evaluation and anti-arthritic assessment
L. Abidin (2016)
10.1016/j.envpol.2008.12.028
Single walled carbon nanotube reactivity and cytotoxicity following extended aqueous exposure.
Barbara J. Panessa-Warren (2009)
10.1289/ehp.7339
Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles
G. Oberdörster (2005)
10.1023/A:1016236932339
A Predictive Algorithm for Skin Permeability: The Effects of Molecular Size and Hydrogen Bond Activity
R. Potts (2004)
10.1038/srep41503
DOE Optimization of Nano-based Carrier of Pregabalin as Hydrogel: New Therapeutic & Chemometric Approaches for Controlled Drug Delivery Systems
Mona G. Arafa (2017)
10.1038/mt.2015.178
Receptor Crosslinking: A General Method to Trigger Internalization and Lysosomal Targeting of Therapeutic Receptor:Ligand Complexes
P. R. Moody (2015)
10.1016/j.ejpb.2011.06.007
pH-responsive nanoparticles releasing tenofovir intended for the prevention of HIV transmission.
T. Zhang (2011)
10.1016/J.BIOENG.2006.05.026
The pinpoint promise of nanoparticle-based drug delivery and molecular diagnosis.
D. Emerich (2006)
Sphingosomes for enhanced drug delivery
エス. ウェブ,ミューライ (1995)
10.1177/28.6.7190175
In situ precipitation: a novel cytochemical technique for visualization of permeability pathways in mammalian stratum corneum.
M. Nemanic (1980)
10.1158/0008-5472.CAN-09-1912
Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompatible magnetic nanoparticles.
M. Loebinger (2009)
10.1016/0378-5173(94)90395-6
Effect of supersaturation on membrane transport: 2. Piroxicam
M. Pellett (1994)
10.3831/KPI.2016.19.005
Nanopharmaceutical Approach for Enhanced Anti-cancer Activity of Betulinic Acid in Lung-cancer Treatment via Activation of PARP: Interaction with DNA as a Target
J. Das (2016)
10.1016/j.ijpharm.2014.11.018
Evaluation of transdermal salidroside delivery using niosomes via in vitro cellular uptake.
Yongtai Zhang (2015)
10.1016/j.jconrel.2008.03.010
Preparation and characterization of PE38KDEL-loaded anti-HER2 nanoparticles for targeted cancer therapy.
H. Chen (2008)
10.2147/IJN.S26766
Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy
Hsin-I Chang (2012)
10.1016/S0378-5173(97)04897-7
Supersaturated solutions evaluated with an in vitro stratum corneum tape stripping technique
M. Pellett (1997)
10.1016/j.jconrel.2016.06.013
Optimizing novel implant formulations for the prolonged release of biopharmaceuticals using in vitro and in vivo imaging techniques.
S. Beyer (2016)
10.1016/j.ejps.2016.08.001
Biopharmaceutic classification of drugs revisited.
Chrysa Daousani (2016)
The emerging nanomedicines landscape
V Wagner (2006)
62 Vesicular carriers, v
V L Vergaro
10.1016/j.nano.2008.06.002
Emerging nanopharmaceuticals.
Willie E. Bawarski (2008)
10.1016/j.jconrel.2016.04.012
Dual chitosan/albumin-coated alginate/dextran sulfate nanoparticles for enhanced oral delivery of insulin.
M. Lopes (2016)
Nanopharmaceuticals : An Overview
A. Gaur (2008)
10.1163/156855206775123494
Nanoparticles for cancer therapy and diagnosis
Y. Fukumori (2006)
10.15171/PS.2017.25
Application of Nanotechnology in Phytochemical Research
S. Sarker (2017)
10.3390/molecules22112040
Solid Lipid Nanoparticles of Albendazole for Enhancing Cellular Uptake and Cytotoxicity against U-87 MG Glioma Cell Lines
Gregory Marslin (2017)
10.2147/IJN.S55359
Nanotherapeutics in the EU: an overview on current state and future directions
A. Hafner (2014)
10.1186/1477-3155-8-15
PVP-coated silver nanoparticles block the transmission of cell-free and cell-associated HIV-1 in human cervical culture
Humberto H Lara (2010)
10.3390/ijms18030628
PAMAM Dendrimers Cross the Blood–Brain Barrier When Administered through the Carotid Artery in C57BL/6J Mice
Bhairavi Srinageshwar (2017)
10.1007/s12645-012-0027-y
PLGA nanoparticles loaded with etoposide and quercetin dihydrate individually: in vitro cell line study to ensure advantage of combination therapy
Smita S. Pimple (2012)
10.1016/j.ijpharm.2009.04.026
Lipid nanocapsules: a new platform for nanomedicine.
N. Huynh (2009)
10.1016/j.jconrel.2014.04.033
Nanoparticle-based drug delivery to the vagina: a review.
Laura M Ensign (2014)
Anti-Cancer Potential of Boswellic Acid: A Mini Review
P. Garg (2015)
10.1023/A:1011037527889
SEM Imaging Predicts Quality of Niosomes from Maltodextrin-Based Proniosomes
A. Blazek-Welsh (2004)
10.3390/ijms19061549
Approaches in Polymeric Nanoparticles for Vaginal Drug Delivery: A Review of the State of the Art
G. Leyva-Gómez (2018)
Nanosuspensions technology in drug delivery
R Dhanapal (2012)
Sphingosomes a novel approach to vesicular drug delivery
S. Saraf (2011)
10.1016/J.CCR.2014.12.014
Fate of engineered nanoparticles: Implications in the environment
A. D. Dwivedi (2015)
10.3390/ijms161024417
In Vitro/In Vivo Toxicity Evaluation and Quantification of Iron Oxide Nanoparticles
Ujwal S. Patil (2015)
10.2147/IJN.S38378
Nanodrugs: pharmacokinetics and safety
S. Onoue (2014)
10.1038/nrd1662
Healing sound: the use of ultrasound in drug delivery and other therapeutic applications
S. Mitragotri (2005)
10.1080/10717540490446044
Sorbitan Monopalmitate-Based Proniosomes for Transdermal Delivery of Chlorpheniramine Maleate
J. Varshosaz (2005)
10.3109/10611860903079454
Niosomes in sustained and targeted drug delivery: some recent advances
A. Azeem (2009)
10.1016/B978-0-12-416020-0.00007-3
Polymer nanoparticles.
Xiaoyun Lu (2011)
10.3892/ol.2014.1898
Damnacanthal is a potent inducer of apoptosis with anticancer activity by stimulating p53 and p21 genes in MCF-7 breast cancer cells
Muhammad Yusran Abdul Aziz (2014)
10.1016/J.JMMM.2005.02.040
Mathematical modelling of magnetically targeted drug delivery
A. Grief (2005)
10.1016/J.FOODCHEM.2011.04.027
Preparation and characterisation of water-soluble phytosterol nanodispersions
Wai Fun Leong (2011)
10.1039/b920570p
PEGylated polymers for medicine: from conjugation to self-assembled systems.
Maisie J. Joralemon (2010)
10.1016/S0009-2509(03)00234-3
Chemotherapeutic engineering: Application and further development of chemical engineering principles for chemotherapy of cancer and other diseases
S. Feng (2003)
10.1002/LSM.20206
Near infrared laser-tissue welding using nanoshells as an exogenous absorber.
A. Gobin (2005)
10.1016/j.jconrel.2012.05.003
Poly-ε-caprolactone microspheres as a drug delivery system for cannabinoid administration: development, characterization and in vitro evaluation of their antitumoral efficacy.
D. Hernán Pérez de la Ossa (2012)
10.1016/S1773-2247(14)50048-2
Skin microporation: strategies to enhance and expand transdermal drug delivery
S. A. Giannos (2014)
10.1021/jf305143k
Curcumin and genistein coloaded nanostructured lipid carriers: in vitro digestion and antiprostate cancer activity.
N. P. Aditya (2013)
10.1016/j.ijpharm.2008.01.051
Preclinical characterisation of NSAIDs in ultradeformable carriers or conventional topical gels.
G. Cevc (2008)
10.1016/j.jconrel.2008.10.002
Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles.
Houli Li (2009)
10.1016/J.AJPS.2015.08.009
Inhalation of nanoparticle-based drug for lung cancer treatment: Advantages and challenges
Wing-Hin Lee (2015)
10.3109/10717544.2014.910564
Evaluation of polyamidoamine dendrimers as potential carriers for quercetin, a versatile flavonoid
Kanika Madaan (2016)
10.1016/j.ejps.2011.04.003
Lipid-mediated gene delivery to the skin.
B. Geusens (2011)
10.1166/JNN.2007.009
Preparation of highly stable oligo(ethylene glycol) derivatives-functionalized gold nanoparticles and their application in LSPR-based detection of PSA/ACT complex.
C. Cao (2007)
10.1007/s11738-015-2008-3
Silymarin: an insight to its formulation and analytical prospects
U. Ahmad (2015)
10.1159/000354402
Epigallocatechin-3-Gallate Inhibits IGF-I-Stimulated Lung Cancer Angiogenesis through Downregulation of HIF-1α and VEGF Expression
X. Li (2013)
10.1016/j.ejpb.2010.03.014
Improvement in physicochemical parameters of DPPC liposomes and increase in skin permeation of aciclovir and minoxidil by the addition of cationic polymers.
A. Hasanovic (2010)
10.1615/CritRevTherDrugCarrierSyst.v13.i3-4.30
Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery.
G. Cevc (1996)
10.1081/DDC-120001481
Nanoparticle Technology for Drug Delivery Across the Blood-Brain Barrier
P. Lockman (2002)
10.1006/nbdi.2002.0550
Molecular Targeting of Alzheimer's Amyloid Plaques for Contrast-Enhanced Magnetic Resonance Imaging
J. Poduslo (2002)
10.1021/NL015681Q
Modifying the Surface Properties of Superparamagnetic Iron Oxide Nanoparticles through A Sol−Gel Approach
Y. Lu (2002)
10.1021/JZ200007H
Polymersomes Spanning from Nano- to Microscales: Advanced Vehicles for Controlled Drug Delivery and Robust Vesicles for Virus and Cell Mimicking
F. Meng (2011)
10.22037/IJPR.2017.2097
Anticancer Activity of Curcumin-Loaded PLGA Nanoparticles on PC3 Prostate Cancer Cells
Seyed Saeed Azandeh (2017)
10.1016/J.JMMM.2005.01.064
Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system
T. Neuberger (2005)
10.4103/0975-7406.103274
Formulation and optimization of nano-sized ethosomes for enhanced transdermal delivery of cromolyn sodium
R. Rakesh (2012)
10.2147/IJN.S37859
Molecular targeting of liposomal nanoparticles to tumor microenvironment
G. Zhao (2013)
10.1016/j.jconrel.2017.03.026
Biomimetics in drug delivery systems: A critical review
M. Sheikhpour (2017)
10.1016/j.preteyeres.2013.04.001
Nanomedicines for back of the eye drug delivery, gene delivery, and imaging
U. Kompella (2013)
10.1016/j.ejps.2015.07.012
A novel approach to arthritis treatment based on resveratrol and curcumin co-encapsulated in lipid-core nanocapsules: In vivo studies.
K. Coradini (2015)
10.1038/cddis.2014.413
Nanoencapsulation of ABT-737 and camptothecin enhances their clinical potential through synergistic antitumor effects and reduction of systemic toxicity
D. Schmid (2014)
10.1016/j.addr.2012.09.037
Liposomal drug delivery systems: from concept to clinical applications.
T. Allen (2013)
10.1016/S1734-1140(12)70901-5
Nanoparticles as drug delivery systems.
A. Z. Wilczewska (2012)
10.1021/np400172k
Antiproliferative activity of abietane diterpenoids against human tumor cells.
O. Burmistrova (2013)
10.1016/j.ijpharm.2015.08.036
Development and ex vivo evaluation of 5-aminolevulinic acid-loaded niosomal formulations for topical photodynamic therapy.
M. Bragagni (2015)
10.1194/jlr.R700013-JLR200
Thematic review series: Skin Lipids. The role of epidermal lipids in cutaneous permeability barrier homeostasis Published, JLR Papers in Press, September 13, 2007.
K. Feingold (2007)
10.1111/nyas.12811
Resveratrol nanoformulation for cancer prevention and therapy.
I. A. Siddiqui (2015)
10.1080/08982100701525035
“Smart” Drug Carriers: PEGylated TATp-Modified pH-Sensitive Liposomes
A. Kale (2007)
10.4049/jimmunol.0900274
Macrophage Delivery of Nanoformulated Antiretroviral Drug to the Brain in a Murine Model of NeuroAIDS1
Huanyu Dou (2009)
10.1517/17425240802691059
Vesicular systems for delivering conventional small organic molecules and larger macromolecules to and through human skin.
G. E. El Maghraby (2009)
10.3109/10717544.2014.889777
Ethosomes: versatile vesicular carriers for efficient transdermal delivery of therapeutic agents
Vikas Pandey (2015)
10.1016/j.ijpharm.2012.10.019
Preparation and evaluation of lidocaine hydrochloride-loaded TAT-conjugated polymeric liposomes for transdermal delivery.
Y. Wang (2013)
10.1021/LA701067R
Single-walled carbon nanotubes exhibit strong antimicrobial activity.
S. Kang (2007)
10.1517/17425247.2016.1130034
Future of the transdermal drug delivery market – have we barely touched the surface?
A. Watkinson (2016)
10.1016/j.tibs.2015.04.004
Glycan variation and evolution in the eukaryotes.
A. Corfield (2015)
10.1016/j.nano.2012.12.006
Pharmaceutically versatile sulfated polysaccharide based bionano platforms.
S. Raveendran (2013)
10.1016/j.envpol.2015.05.008
Toxicokinetics and tissue distribution of cadmium-based Quantum Dots in the marine mussel Mytilus galloprovincialis.
T. Rocha (2015)
10.3109/17435390.2011.648667
Cadmium telluride quantum dot nanoparticle cytotoxicity and effects on model immune responses to Pseudomonas aeruginosa
K. Nguyen (2013)
10.1016/J.ATHEROSCLEROSIS.2007.10.033
Effects of plant stanol esters on serum cholesterol concentrations, relative markers of cholesterol metabolism and endothelial function in type 1 diabetes.
M. Hallikainen (2008)
10.3892/ETM.2015.2749
Biological and therapeutic activities, and anticancer properties of curcumin.
D. Perrone (2015)
10.1007/978-3-642-48391-2_3
Basic Principles of Liposomes for Drug Use
G. Martin (1992)
10.1080/10408398.2015.1031337
Solid lipid nanoparticles as oral delivery systems of phenolic compounds: Overcoming pharmacokinetic limitations for nutraceutical applications
Sara Nunes (2017)
10.1016/j.carbpol.2015.06.102
Encapsulation of honokiol into self-assembled pectin nanoparticles for drug delivery to HepG2 cells.
Y. Zhang (2015)
10.1001/archderm.1962.01590110044005
Method for Comparing Percutaneous Absorption of Steroids
A. W. Mckenzie (1962)
10.1016/J.APT.2011.06.005
Improved oral delivery of valsartan from maltodextrin based proniosome powders
Alekhya Gurrapu (2012)
10.3109/02652049009040470
Dermal drug delivery by liposome encapsulation: clinical and electron microscopic studies.
M. Foldvari (1990)
10.1016/j.biomaterials.2012.03.070
Pharmacokinetics of a paclitaxel-loaded low molecular weight heparin-all-trans-retinoid acid conjugate ternary nanoparticulate drug delivery system.
L. Hou (2012)
10.1016/j.urolonc.2007.03.015
Nanoparticles for drug delivery in cancer treatment.
B. Haley (2008)
10.1016/S1875-5364(15)30061-3
Biocompatible and biodegradable nanoparticles for enhancement of anti-cancer activities of phytochemicals.
C. Li (2015)
10.1016/j.jconrel.2012.05.050
Improved in vitro and in vivo collagen biosynthesis by asiaticoside-loaded ultradeformable vesicles.
D. Paolino (2012)
10.1166/JBN.2010.1152
Drug delivery applications with ethosomes.
D. Ainbinder (2010)
10.1016/j.jphotobiol.2015.03.007
Integrative approach in prevention and therapy of basal cellular carcinoma by association of three actives loaded into lipid nanocarriers.
G. Badea (2015)
10.1016/j.ijpharm.2013.05.007
Trans-resveratrol loaded chitosan nanoparticles modified with biotin and avidin to target hepatic carcinoma.
L. Bu (2013)
10.15171/apb.2015.074
Nanoethosomes for Dermal Delivery of Lidocaine.
Soraya Babaie (2015)
10.1002/ADMA.200300010
Vesicles and Liposomes: A Self-Assembly Principle Beyond Lipids†
M. Antonietti (2003)
10.1093/abbs/gmt063
Superior anticancer efficacy of curcumin-loaded nanoparticles against lung cancer.
Haitao Yin (2013)
Structural and biological mimicry of protein surface recognition by alpha/beta-peptide foldamers
W S Horne (2009)
10.5339/gcsp.2015.2
Inhaled nano- and microparticles for drug delivery
I. ElSherbiny (2015)
10.1007/978-1-4614-7801-0_4
Grassroots Innovation: A Promising Innovation Paradigm for Pharmaceutical Companies
Ulrich A. K. Betz (2014)
10.22038/NMJ.2013.697
Nano-niosomes in drug, vaccine and gene delivery: a rapid overview
A. Pardakhty (2013)
10.1586/14760584.7.8.1141
Epaxal®: a virosomal vaccine to prevent hepatitis A infection
P. Bovier (2008)
10.1016/j.ejps.2012.12.010
Transdermal absorption enhancement of papain loaded in elastic niosomes incorporated in gel for scar treatment.
A. Manosroi (2013)
10.1038/nrd1304
Current status and future potential of transdermal drug delivery
M. Prausnitz (2004)
10.1177/0192623307310950
The Application of Fluorescent Quantum Dots to Confocal, Multiphoton, and Electron Microscopic Imaging
T. Deerinck (2008)
10.1517/17425247.5.9.1003
Antibody-modified liposomes for cancer chemotherapy.
V. Torchilin (2008)
10.2147/IJN.S92162
Natural product-based nanomedicine: recent advances and issues
R. Watkins (2015)
10.1021/es2038596
Stability of citrate, PVP, and PEG coated silver nanoparticles in ecotoxicology media.
M. Tejamaya (2012)
10.1038/nrrheum.2016.193
Immune resolution mechanisms in inflammatory arthritis
M. Perretti (2017)
10.1016/j.drudis.2012.05.007
Drug discovery in pharmaceutical industry: productivity challenges and trends.
I. Khanna (2012)
10.1126/SCIENCE.284.5422.1994
Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.
J. Holash (1999)
10.1016/S0168-3659(97)00100-4
Proniosome based transdermal delivery of levonorgestrel for effective contraception.
B. Vora (1998)
Nanoparticle-based therapeutics in humans: a survey
R Bawa (2008)
Disposal by flushing of certain unused medicines: what you should know
10.1002/cbdv.201300326
Chemical Composition and Biological Activity of the Essential Oil of Origanum vulgare ssp. hirtum from Different Areas in the Southern Apennines (Italy)
E. Mancini (2014)
10.1016/J.JCONREL.2005.09.006
Evaluation of constant current alternating current iontophoresis for transdermal drug delivery.
G. Yan (2005)
10.1016/0168-3659(95)00127-1
Effects of phospholipids on the percutaneous penetration of indomethacin through the dorsal skin of guinea pigs in vitro
Y. Yokomizo (1996)
10.1021/js950415w
Controlled transdermal delivery of fentanyl: characterizations of pressure-sensitive adhesives for matrix patch design.
Saumendu Deb Roy (1996)
10.1021/BC060240P
Dendrimer versus linear conjugate: Influence of polymeric architecture on the delivery and anticancer effect of paclitaxel.
J. Khandare (2006)
10.1039/C4TB01083C
Combinatorial approach in the design of multifunctional polymeric nano-delivery systems for cancer therapy.
A. Singh (2014)
10.1039/c2nr11606e
Transdermal drug delivery: from micro to nano.
Carla Pegoraro (2012)
10.1211/0022357001774804
Ion-pair formation as a strategy to enhance topical delivery of salicylic acid.
S. A. Megwa (2000)
10.1111/j.1349-7006.1988.tb01563.x
Involvement of the Kinin‐generating Cascade in Enhanced Vascular Permeability in Tumor Tissue
Yasuhiro Matsumura (1988)
10.13188/2380-5021.1000006
Bilosomes Based Drug Delivery System
Ramchandra N. Chilkwar (2015)
10.1016/j.jes.2014.08.024
Accumulation and elimination of iron oxide nanomaterials in zebrafish (Danio rerio) upon chronic aqueous exposure.
Y. Zhang (2015)
10.1016/0169-409X(95)00091-K
The skin: a pathway for systemic treatment with patches and lipid-based agent carriers
G. Cevc (1996)
10.1016/j.nano.2008.01.001
Nanotoxicology and nanomedicine: making hard decisions.
I. Linkov (2008)
Progress in Nanomedicine: Approved and Investigational Nanodrugs.
C. Ventola (2017)
10.1517/14712598.6.4.409
Sphingomyelin/cholesterol liposomal vincristine: a new formulation for an old drug
L. Boehlke (2006)
10.1016/0031-6865(95)00010-7
Preparation and characterization of liposomes as therapeutic delivery systems: a review.
S. Vemuri (1995)
10.4172/2155-952X.1000276
Liposomes for Drug Delivery
Durgavati Yadav (2017)
10.3109/10717544.2016.1141258
Targeted delivery of etoposide to cancer cells by folate-modified nanostructured lipid drug delivery system
S. Zhang (2016)
10.3390/nano7060122
A Review of the Structure, Preparation, and Application of NLCs, PNPs, and PLNs
Qianwen Li (2017)
10.1016/J.IJPHARM.2007.06.036
Preparation, physicochemical characterization, and antioxidant effects of quercetin nanoparticles.
Tzu-Hui Wu (2008)
10.1021/js950534b
Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization.
T. Loftsson (1996)
10.1038/srep11760
Novel ZnO hollow-nanocarriers containing paclitaxel targeting folate-receptors in a malignant pH-microenvironment for effective monitoring and promoting breast tumor regression
N. Puvvada (2015)
10.1016/J.IJPHARM.2005.11.045
Niosomes as carriers for tretinoin. III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin.
M. Manconi (2006)
10.1016/J.CPLETT.2016.12.019
A targeted drug delivery system based on dopamine functionalized nano graphene oxide
E. Masoudipour (2017)
10.1016/J.BBAGEN.2006.12.007
Targeting potential and anti-HIV activity of lamivudine loaded mannosylated poly (propyleneimine) dendrimer.
T. Dutta (2007)
10.1016/J.PHYSE.2004.07.013
Quantum dots in biology and medicine
R. E. Bailey (2004)
10.1016/j.ijpharm.2012.05.007
Stabilized terbutaline submicron drug aerosol for deep lungs deposition: drug assay, pulmonokinetics and biodistribution by UHPLC/ESI-q-TOF-MS method.
Md Faiyazuddin (2012)
PREPARATION AND IN-VITRO EVALUATION OF DICLOFENAC SODIUM NIOSOMAL FORMULATIONS
Marwa Helmy Abedullahh (2013)
10.1016/J.COPH.2006.05.004
Crossing cellular barriers using dendrimer nanotechnologies.
Mohammad Najlah (2006)
Toxicity and Environmental Risks of Nanomaterials : Challenges and Future Needs
P. P. Latha (2016)
10.1152/AJPLUNG.00277.2005
Smaller is not always better: nanotechnology yields nanotoxicology.
H. Kipen (2005)
10.3109/08982104.2014.950276
Preparation of transfersomes encapsulating sildenafil aimed for transdermal drug delivery: Plackett–Burman design and characterization
T. Ahmed (2015)
10.1016/j.biotechadv.2010.10.003
A biotechnological perspective on the application of iron oxide magnetic colloids modified with polysaccharides.
Ana M.G.C. Dias (2011)
10.3109/02652048.2011.629742
Preparation of coenzyme Q10 liposomes using supercritical anti-solvent technique
Fei Xia (2012)
10.1016/j.addr.2016.04.025
Challenges and strategies in anti-cancer nanomedicine development: An industry perspective.
J. I. Hare (2017)
10.3109/1061186X.2015.1078338
Synthesis and evaluation of a glutamic acid-modified hPAMAM complex as a promising versatile gene carrier
M. Hemmati (2016)
10.1016/j.ejps.2015.12.031
Recent advances in polymeric micelles for anti-cancer drug delivery.
Swati Biswas (2016)
10.2217/17435889.1.3.297
Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential
M. Immordino (2006)
NIOSOMES – CHALLENGE IN PREPARATION FOR PHARMACEUTICAL SCIENTIST
RAJESH Z. MUJORIYAA (2011)
10.2147/IJN.S78988
Fabrication of genistein-loaded biodegradable TPGS-b-PCL nanoparticles for improved therapeutic effects in cervical cancer cells
Hongling Zhang (2015)
10.1016/j.nano.2008.12.005
Study of artemisinin nanocapsules as anticancer drug delivery systems.
Youfang Chen (2009)
10.1016/J.JCONREL.2007.08.013
Temperature-sensitive hydrogels with SiO2-Au nanoshells for controlled drug delivery.
M. Bikram (2007)
Effect of circulation on the disposition and ocular tissue distribution of 20 nm nanoparticles after periocular administration
A. Amrite (2008)
10.1002/smll.200801716
Toxicity assessments of multisized gold and silver nanoparticles in zebrafish embryos.
Ofek Bar-Ilan (2009)
10.1002/SMLL.200600009
Methotrexate-immobilized poly(ethylene glycol) magnetic nanoparticles for MR imaging and drug delivery.
N. Kohler (2006)
10.1016/J.PROCHE.2012.06.046
Development of Ethosomes Containing Mycophenolic Acid
T. Limsuwan (2012)
10.1016/j.addr.2012.09.022
PEGylated nanoparticles for biological and pharmaceutical applications.
H. Otsuka (2003)
10.1007/s10787-007-1609-x
Anti-inflammatory effect of α, β-Amyrin, a pentacyclic triterpene from Protium heptaphyllum in rat model of acute periodontitis
S. A. Holanda Pinto (2007)
10.2741/2289
Inflammation and wound healing.
T. Oberyszyn (2007)
10.1016/0005-2736(73)90408-2
Single bilayer liposomes prepared without sonication.
S. Batzri (1973)
10.1080/10837450.2017.1330345
Formulation and characterization of Phospholipon 90 G and tween 80 based transfersomes for transdermal delivery of eprosartan mesylate
A. Ahad (2018)
A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.
Y. Matsumura (1986)
10.1016/j.ejpb.2014.04.017
In vitro combinatorial anticancer effects of 5-fluorouracil and curcumin loaded N,O-carboxymethyl chitosan nanoparticles toward colon cancer and in vivo pharmacokinetic studies.
A. Anitha (2014)
Environmental risk assessment, vi
Proteosome inhibition mediates p53 reactivation and anticancer activity of 6-gingerol in cervical cancer cells
N Rastogi (2015)
Dendrimers: properties and application
K Barbara (2001)
10.1016/j.joi.2010.10.007
A bibliometric investigation of research performance in emerging nanobiopharmaceuticals
Kaihua Chen (2011)
10.1007/s11051-014-2527-7
Overview of nano-drugs characteristics for clinical application: the journey from the entry to the exit point
Tanima Bose (2014)
10.1016/S0378-5173(00)00669-4
In vitro skin permeation of estradiol from various proniosome formulations.
J. Fang (2001)
10.4172/2155-983X.1000143
Introduction of Nanotechnology in Herbal Drugs and Nutraceutical: A Review
S. Gopi (2016)
10.1590/S1984-82502013000700006
Dendrimers as anti-inflammatory agents
P. K. Avti (2013)
10.1021/mp900090z
Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery.
Emily Gullotti (2009)
10.1002/jps.22446
Preparation and characterization of quercetin nanocrystals.
N. G. Sahoo (2011)
10.1158/1055-9965.EPI-15-0578
Global Cancer Incidence and Mortality Rates and Trends—An Update
L. Torre (2015)
10.1016/j.ejpb.2013.04.018
Silver sulfadiazine based cubosome hydrogels for topical treatment of burns: development and in vitro/in vivo characterization.
N. Morsi (2014)
10.3390/molecules17055972
Preparation of Curcumin-Loaded Liposomes and Evaluation of Their Skin Permeation and Pharmacodynamics
Y. Chen (2012)
10.1080/10717540801905165
Polyelectrolyte biomaterial interactions provide nanoparticulate carrier for oral insulin delivery.
C. Reis (2008)
10.1039/c5em00329f
Copper nanoparticles/compounds impact agronomic and physiological parameters in cilantro (Coriandrum sativum).
Nubia Zuverza-Mena (2015)
10.1002/etc.3039
Nanopharmaceuticals: Tiny challenges for the environmental risk assessment of pharmaceuticals.
Silvia Berkner (2016)
10.1016/J.BBMT.2005.10.004
Bionanotechnology progress and advances.
W. Chan (2006)
10.1016/J.CAP.2007.10.011
Carbon nanotubes as drug delivery nanocapsules
Tamsyn A. Hilder (2008)
10.1016/j.ijpharm.2008.05.031
Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes.
M. Mokhtar (2008)
10.1016/J.VACCINE.2006.04.030
Development of novel fusogenic vesosomes for transcutaneous immunization.
V. Mishra (2006)
10.1517/17425247.2014.924499
Vaginal drug delivery: strategies and concerns in polymeric nanoparticle development
T. Wong (2014)
10.2147/IJN.S104701
Current application of phytocompound-based nanocosmeceuticals for beauty and skin therapy
P. Ganesan (2016)
10.1007/s11095-006-9207-y
Development of Biodegradable Nanoparticles for Oral Delivery of Ellagic Acid and Evaluation of Their Antioxidant Efficacy Against Cyclosporine A-Induced Nephrotoxicity in Rats
K. Sonaje (2006)
10.1016/J.FOODRES.2014.05.059
Solid lipid nanoparticles enhance oral bioavailability of resveratrol, a natural polyphenol
Deepti Pandita (2014)
10.1211/002235702135
Human skin sandwich for assessing shunt route penetration during passive and iontophoretic drug and liposome delivery.
Ebtessam A. Essa (2002)
10.1158/0008-5472.CAN-09-1083
Enhanced leukemia cell detection using a novel magnetic needle and nanoparticles.
Jason E. Jaetao (2009)
10.2174/1567201811666140115113127
Penetration of tamoxifen citrate loaded ethosomes and liposomes across human skin: a comparative study with confocal laser scanning microscopy.
K. Sarwa (2014)
10.1016/j.ejpb.2016.08.017
Paclitaxel-loaded PEGylated nanocapsules of perfluorooctyl bromide as theranostic agents.
Tanguy Boissenot (2016)
10.1039/c6ib00234j
Biocompatibility and therapeutic evaluation of magnetic liposomes designed for self-controlled cancer hyperthermia and chemotherapy.
Manashjit Gogoi (2017)
10.3109/10717544.2012.727500
Thymoquinone in liposomes: a study of loading efficiency and biological activity towards breast cancer
F. Odeh (2012)
10.1016/j.jconrel.2012.09.017
Approaches for breaking the barriers of drug permeation through transdermal drug delivery.
A. Alexander (2012)
10.2147/IJN.S595
Nanocrystal technology, drug delivery and clinical applications
Jens-Uwe A. H. Junghanns (2008)
10.1007/s00011-009-0037-3
Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease
A. García-Lafuente (2009)
10.1016/S1359-0294(00)00090-X
Liposome application: problems and prospects
Y. Barenholz (2001)
10.4155/tde.15.66
Current and emerging lipid-based systems for transdermal drug delivery.
S. K. Singla (2015)
10.1166/JBN.2016.2207
Curcumin-ER Prolonged Subcutaneous Delivery for the Treatment of Non-Small Cell Lung Cancer.
A. Ranjan (2016)
10.3390/antiox7010003
Natural Nanoparticles: A Particular Matter Inspired by Nature
S. Griffin (2017)
10.1089/cbr.2009.0724
Anticancer activity and molecular mechanism of resveratrol-bovine serum albumin nanoparticles on subcutaneously implanted human primary ovarian carcinoma cells in nude mice.
Li-Yuan Guo (2010)
10.1021/JA048548J
Cytotoxicity, hemolysis, and acute in vivo toxicity of dendrimers based on melamine, candidate vehicles for drug delivery.
Hui-Ting Chen (2004)
10.1200/JCO.1997.15.3.987
Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation.
F. Muggia (1997)
10.1007/s10856-017-5900-0
Design and characterization of lisinopril-loaded superparamagnetic nanoparticles as a new contrast agent for in vitro, in vivo MRI imaging, diagnose the tumors and drug delivery system
Sajjad Abbasi Pour (2017)
10.1016/j.jfda.2017.02.001
Recent advances in oral delivery of drugs and bioactive natural products using solid lipid nanoparticles as the carriers.
C. Lin (2017)
10.1021/acs.langmuir.7b00742
Elegant pH-Responsive Nanovehicle for Drug Delivery Based on Triazine Dendrimer Modified Magnetic Nanoparticles.
Amir Landarani-Isfahani (2017)
10.2174/1567201815666171207163010
Formulation Optimization and In-vitro and In-vivo Evaluation of Lornoxicam Ethosomal Gels with Penetration Enhancers.
KeKe Li (2018)
10.1111/jphp.12946
Protective effect of methylsulfonylmethane in caerulein‐induced acute pancreatitis and associated lung injury in mice
Ranjith Kumar Velusamy (2018)
10.3402/nano.v1i0.5161
Semiconductor quantum dots as fluorescent probes for in vitro and in vivo bio-molecular and cellular imaging
S. B. Rizvi (2010)
10.3390/molecules20022492
Production and Characterization of Cosmetic Nanoemulsions Containing Opuntia ficus-indica (L.) Mill Extract as Moisturizing Agent
Renato César de Azevedo Ribeiro (2015)
10.1016/j.biotechadv.2016.04.002
Nanotechnology for the delivery of phytochemicals in cancer therapy.
J. Xie (2016)
10.1155/2015/263131
Thymoquinone-Loaded Nanostructured Lipid Carrier Exhibited Cytotoxicity towards Breast Cancer Cell Lines (MDA-MB-231 and MCF-7) and Cervical Cancer Cell Lines (HeLa and SiHa)
W. K. Ng (2015)
10.1016/j.canlet.2013.02.032
Bioavailability of phytochemicals and its enhancement by drug delivery systems.
F. Aqil (2013)
10.1016/J.IMPACT.2017.08.001
Biomolecular coronas in invertebrate species: Implications in the environmental impact of nanoparticles
L. Canesi (2017)
Food hydrocolloids applications of chitosan nanoparticles to enhance absorption and bioavailability of tea polyphenols : a review. Food Hydrocoll
J Liang (2017)
Nanotechnology based chemopreventive approaches to improve the oral delivery of Silymarin in liver cancer
U Ahmad (2015)
Nanoparticles for systemic medicines and imaging agents
M E Davis (2006)
10.1007/978-1-4614-7801-0_6
Evaluating the Impact of Treatment Effectiveness and Side Effects in Prescribing Choices
Tat Y. Chan (2014)
Test no. 40: ecotoxicology and environmental fate of manufactured nanomaterials-Expert meeting report
Oecd (2014)
10.1021/acsami.7b06393
Dual-Mode Imaging-Guided Synergistic Chemo- and Magnetohyperthermia Therapy in a Versatile Nanoplatform To Eliminate Cancer Stem Cells.
Jinglong Tang (2017)
10.5138/IJDD.2010.0975.0215.03050
Niosomes as vesicular carriers for delivery of proteins and biologicals
S. Shilpa (2011)
10.1128/AAC.00450-16
Topical Tenofovir Disoproxil Fumarate Nanoparticles Prevent HIV-1 Vaginal Transmission in a Humanized Mouse Model
C. Destache (2016)
10.1152/ajpheart.1998.274.6.H2062
Test of a two-pathway model for small-solute exchange across the capillary wall.
B. Fu (1998)
10.2147/IJN.S4241
Nanoparticles and cancer therapy: A concise review with emphasis on dendrimers
D. Bharali (2009)
10.1002/anie.200906927
Gold nanorods in photodynamic therapy, as hyperthermia agents, and in near-infrared optical imaging.
Wen-Shuo Kuo (2010)
10.2174/156720106775197493
DNA delivery for vaccination and therapeutics through the skin.
M. Foldvari (2006)
10.1088/0957-4484/21/23/235603
Synthesis, characterization and magnetic properties of nearly monodisperse CuCr2Se4 nanoparticles.
C. Lin (2010)
10.3390/md12126236
Design of Chitosan and Its Water Soluble Derivatives-Based Drug Carriers with Polyelectrolyte Complexes
Qing-Xi Wu (2014)
10.22038/IJBMS.2011.5051
Preparation, Characterization and Evaluation of Sun Protective and Moisturizing Effects of Nanoliposomes Containing Safranal
S. Golmohammadzadeh (2011)
10.1126/SCIENCE.1104274
Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics
X. Michalet (2005)
10.1208/pt0804098
Designing chitosan-dextran sulfate nanoparticles using charge ratios
Y. Chen (2008)
10.1166/JNN.2008.274
New aspects of nanopharmaceutical delivery systems.
P. D. Marcato (2008)
10.1517/17425240903338055
Nanoparticle-based vaginal drug delivery systems for HIV prevention
R. Mallipeddi (2010)
10.1002/smll.200800003
Particle size, surface coating, and PEGylation influence the biodistribution of quantum dots in living mice.
M. L. Schipper (2009)
Polymersome Macromolecule Delivery across Intact Human Skin
Carla Pegoraro (2011)
10.3892/ol.2017.5986
Resistance to nanoparticle albumin-bound paclitaxel is mediated by ABCB1 in urothelial cancer cells
S. Vallo (2017)
10.1186/1477-3155-5-3
Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy
S. Bisht (2007)
10.2147/IJN.S93426
Today’s diverse nano-theranostic applications and tomorrow’s promises
T. Webster (2015)
10.1016/j.jconrel.2008.05.010
Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles.
F. Kratz (2008)
10.2147/IJN.S35288
Nanodrugs: optimism for emerging trend of multidrug resistance
A. Khan (2012)
10.1021/MP049928E
Drug-loaded carbon nanohorns: adsorption and release of dexamethasone in vitro.
T. Murakami (2004)
10.1016/J.IJPHARM.2007.06.050
Biodistribution of intravenously administered amphiphilic beta-cyclodextrin nanospheres.
A. Géze (2007)
10.1016/j.colsurfb.2016.07.021
Ethosomes for enhanced skin delivery of griseofulvin.
J. Marto (2016)
10.1007/S10544-016-0134-3
Ethosomes and organogels for cutaneous administration of crocin
E. Esposito (2016)
10.2147/IJN.S131295
Triple-functional albumin-based nanoparticles for combined chemotherapy and photodynamic therapy of pancreatic cancer with lymphatic metastases
Xinzhe Yu (2017)
10.1016/S0169-409X(02)00113-8
Drug delivery routes in skin: a novel approach.
B. Barry (2002)
10.1142/9781860949074_0014
Drug Nanocrystals/Nanosuspensions for the Delivery of Poorly Soluble Drugs
R. Mueller (2006)
10.1039/C6EN00332J
Ecotoxic effects of paclitaxel-loaded nanotherapeutics on freshwater algae, Raphidocelis subcapitata and Chlamydomonas reinhardtii
Yagmur Yegin (2017)
10.4314/TJPR.V6I2.14647
Design and Development of a Proniosomal Transdermal Drug Delivery System for Captopril
A. Gupta (2007)
10.4018/978-1-5225-0585-3.CH013
Ecotoxicity and Toxicity of Nanomaterials with Potential for Wastewater Treatment Applications
V. Nogueira (2017)
10.1007/s10147-015-0788-5
Mechanisms of hormonal therapy resistance in breast cancer
S. Hayashi (2015)
10.1038/aps.2012.34
Enhancement of cellular uptake and cytotoxicity of curcumin-loaded PLGA nanoparticles by conjugation with anti-P-glycoprotein in drug resistance cancer cells
Wanisa Punfa (2012)
10.1517/17425247.2015.1070143
Recent developments in novel drug delivery systems for wound healing
L. Pachuau (2015)
10.3390/polym9060224
Polyamidoamine (PAMAM) Dendrimers Modified with Cathepsin-B Cleavable Oligopeptides for Enhanced Gene Delivery
S. Lee (2017)
10.1016/j.biomaterials.2010.03.069
Surface functionalisation of PLGA nanoparticles for gene silencing.
M. Ø. Andersen (2010)
10.1021/bc900422j
Tumor-targeting, pH-responsive, and stable unimolecular micelles as drug nanocarriers for targeted cancer therapy.
Xiaoqiang Yang (2010)
10.1111/php.12419
Evaluation of Photoprotective Potential and Percutaneous Penetration by Photoacoustic Spectroscopy of the Schinus terebinthifolius Raddi Extract.
Milena Keller Bulla (2015)
10.1016/j.jconrel.2015.11.005
Poly(ethylenimine) conjugated bioreducible dendrimer for efficient gene delivery.
Kihoon Nam (2015)
10.3390/ijms18040709
Recent Advances in Nanoparticle-Mediated Delivery of Anti-Inflammatory Phytocompounds
R. Conte (2017)
10.1016/j.ejpb.2017.07.009
Synthesis and characterization of a multifunctional gold‐doxorubicin nanoparticle system for pH triggered intracellular anticancer drug release
Ganesh V. Khutale (2017)
10.3390/ijms140815977
Tuning the Magnetic Properties of Nanoparticles
Arati G. Kolhatkar (2013)
10.1016/j.colsurfb.2016.04.001
Resveratrol-loaded nanocapsules inhibit murine melanoma tumor growth.
Bruna Carletto (2016)
10.1517/17425247.2013.771630
Nanopharmaceuticals to target antifilarials: a comprehensive review
M. Ali (2013)
Aspectos gerais em sistemas transdérmicos de liberação de fármacos General aspects in transdermal systems of drugs release
Marlus Chorilli
10.1126/SCIENCE.1114397
Toxic Potential of Materials at the Nanolevel
A. Nel (2006)
10.22159/IJPPS.2016.V8I9.12993
ANTICANCER ACTIVITY OF SILVER NANOBIOCONJUGATES SYNTHESISED FROM PIPER BETLE LEAVES EXTRACT AND ITS ACTIVE COMPOUND EUGENOL
R. Preethi (2016)
10.1038/nrd2008
Cellular imaging in drug discovery
P. Lang (2006)
10.1016/J.EJPHAR.2006.12.005
Mechanisms underlying the inhibitory actions of the pentacyclic triterpene alpha-amyrin in the mouse skin inflammation induced by phorbol ester 12-O-tetradecanoylphorbol-13-acetate.
R. Medeiros (2007)
10.2174/1567201812666150703115126
Benzocaine loaded solid lipid nanoparticles: Formulation design, in vitro and in vivo evaluation of local anesthetic effect.
M. Basha (2015)
10.3389/fphar.2015.00219
Lipid-based nano-delivery systems for skin delivery of drugs and bioactives
Susan Hua (2015)
10.3109/02652049509087252
Preparation and characterization of niosomes containing rifampicin for lung targeting.
C. Jain (1995)
10.1016/j.ijpharm.2017.05.029
Sertaconazole nitrate loaded nanovesicular systems for targeting skin fungal infection: In-vitro, ex-vivo and in-vivo evaluation.
M. Abd-El-latif (2017)



Semantic Scholar Logo Some data provided by SemanticScholar